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Abstract 
 
 
Objective: To test the efficacy of the QScan oral hygiene device used by patients 
with fixed orthodontics appliances and its effect on plaque accumulation and 
demineralisation.  
Design and Setting: A prospective randomised control trial was undertaken at 
Liverpool University Dental Hospital.  
Materials and methods: Sixty patients with upper and lower fixed orthodontic 
appliances were recruited and randomly divided into two groups. The intervention 
group was provided with the QScan device to use as an at home oral hygiene 
adjunct. The control group were asked to continue with thier oral hygiene care at 
home without the use of QScan. Both groups were assessed over a period of three 
orthodontic appointments. At each visit Quantitative Light Fluorescence Induced - 
Digital (QLF-D) photographs were taken of the dentition in an aim to quantify the 
amount of plaque and demineralisation.  
Results: Fifty-six (93.3%) participants completed the study. There was a total 
reduction in plaque accumulation in the QScan group, which was statistically 
significant (p<0.001) when compared to the control group (t-test analysis). Though 
there was an evident reduction in plaque accumulation, this did not reflect on the 
levels of demineralisation. Data analysis revealed that the changes in 
demineralisation between the QScan and control group were insignificant (p>0.05).  
Conclusions: The Qscan device has shown to be an effective adjunct for plaque 
control in orthodontic patients following a longitudinal assessment. However, this 
reduction did not translate to a significant reduction in demineralisation following an 
average 15 week assessment. 
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1.0 Introduction 
 
In Orthodontics, the use of fixed appliance components such as bands, brackets and 
archwires makes the daily maintenance of oral hygiene more of a challenge. This is 
due to the increase in the number of stagnation sites (Van der Veen et al. 2007) and 
as plaque matures the number and volume of bacteria increases (Rosenbloom & 
Tinanoff 1991). Plaque is a well-documented aetiological factor in the 
demineralisation of tooth substance (Atack et al. 1996), and in severe cases this may 
lead to unsightly marks on tooth surfaces. This can even progress to cavitation 
requiring restoration (Benson et al. 2003). In addition to this, periodontal 
inflammation often occurs as a consequence of increased plaque accumulation, 
which increases the risk of periodontal disease (Zotti et al. 2016). 
 
A high proportion of patients who undergo Orthodontic treatment are at the 
transitional period between puberty and adulthood. Their “manual ability and overall 
motivation regarding oral hygiene maintenance are often suboptimal”. This is thought 
to be related to a number of complex factors, including concerns in relation to the 
appearance of their fixed appliances, feelings of discomfort and sometimes bullying 
as a result of their malocclusion, or as a result of the orthodontic intervention itself. 
Young individuals are proficient in using smart phones and devices in order to 
communicate, learn and share information (Zotti et al. 2016). For this reason, it may 
be thought that the use of a device which assists with oral hygiene may motivate and 
educate people to improve plaque control. Thus potentially reducing the occurrence 
of demineralisation during fixed appliance therapy. 
 
There have been numerous dental advancements that aid patients in their at home 
oral care. Some have been investigated continuously with various methods of 
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research (Yaacob et al. 2014). Others lack high quality evidence supporting their 
efficiency. A recent technological advancement in plaque detection has been the 
development of the QScan device (Inspektor Research Systems, Amsterdam). This 
device utilises light emitting diodes (LED) in an aim to detect plaque accumulation. 
The areas of plaque that patients are missing when brushing becomes very evident 
using this ‘at home’ device. The concept of having a plaque detecting device to use 
at home is very thought-provoking, however the efficacy of this device remains 
uncertain. A great concept may not necessarily be one of benefit. 
 
The randomised controlled trial reported in this thesis investigated the influence of 
the QScan device as part of an “at home” oral hygiene routine. This study compared 
the levels of plaque accumulation (primary outcome) and demineralisation 
(secondary outcome) in patients using the QScan device when compared to a 
control group. All the participants were recruited in the Orthodontic Department at 
the Liverpool University Dental Hospital. Participants in both groups received all of 
the regular oral hygiene advice for orthodontic patients. Therefore, they were not 
disadvantaged when compared to orthodontic patients at the department. Data was 
gathered in the form of Quantitative Light Induced Fluorescence – Digital (QLF-D) 
photographs which were analysed following assessment of intra and inter reliability 
with an experienced QLF researcher (GK). Levels of plaque and demineralisation 
were quantified using the QLF-D system. Statistical analysis was completed using 
SPSS software (version 24.0, IBM Corporation, Armonk, NY, USA) with the 
assistance of an experienced statistician (GB).  
 
This thesis consists of 10 chapters starting with a detailed literature review, which 
will discuss the main aetiological factors related to demineralisation and dental 
caries. This will be followed by methods of assessing oral health related to 
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demineralisation, including the evidence based methods proposed to ensuring 
satisfactory oral care. The aims and objectives related to testing the efficacy of the 
QScan device will be described in chapter 3, followed by the methods to test the null 
hypothesis. The results chapter will be followed by a discussion interpreting the 
findings and a final conclusion for the study. The final chapters will outline 
documents related to the study and all the references used in this thesis. 
2.0 Literature review 
 
In this literature review the evidence available in relation to the aetiology of 
demineralisation will be outlined. Important preventive approaches including patient 
information and oral health promotion methods will also be discussed, followed by a 
summary of various methods to identify both plaque and demineralisation. 
2.1 Aetiology of Dental Caries 
 
Miller (1988) described dental caries as a dynamic process that occurs due to the 
association between four main factors. The tooth surface, the substrate in the 
presence of plaque over a time period. This has been diagrammatically presented as 
follows (Figure 1): 
 
 
 
 
 
 
 
 
Figure 1: Basic diagrammatic process of caries (Miller 1988) 
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This basic diagram displays the main process in relation to dental caries. The 
process of dental caries extends beyond these basic elements. Risk factors are 
known to play a direct role in the final result of caries. Fejerskov and Manji (2010) 
combined this basic process with the risk factors associated with dental caries 
(Figure 2): 
 
Figure 2: Illustration of the basic process with the risk factors associated (Fejerskov 
& Manji 2010) 
 
The cause of dental caries as evident in Figure 2 is a complex process. It stems 
beyond the basic physiological process of plaque formation in the presence of a 
substrate, and the acidic effects on teeth over time. The factors that directly 
contribute to dental caries are effected by the oral environment and personal factors 
as well. The understanding of dental caries and its aetiology is key in limiting the 
risks for dental caries. The aim would be to either directly tackle the basic process of 
dental caries (Figure 1) or to tackle the more general factors which may be related to 
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dental caries (Figure 2). This is dependent on the complications a patient may 
present with. As an example, a patient that doesn’t have dental insurance and 
access to dental treatment in some areas of the world may have an increased risk of 
dental caries which needs to be addressed. Luckily, this is not the case in the UK 
with National Health Service dental treatment being available. This particular point 
would be considered as a personal factor (Figure 2) which is a complication that 
extends beyond the basic physiological process in figure 1. 
2.2 Plaque/Bacterial biofilm 
 
Dental plaque has been defined as “the diverse community of microorganisms found 
on the tooth surface as a biofilm, embedded in an extracellular matrix of polymers of 
host and microbial origin” (Marsh 2004). The process of caries can occur on any 
tooth surface with the presence of dental plaque for a substantial amount of time 
(Fejerskov 2004). Plaque is a key factor in the development and pathogenesis of 
caries and periodontal disease (Axelsson et al. 2004). There are 5 distinct phases of 
plaque development as described by Marsh (Marsh 2004): 
 
a) Adsorption of host and bacterial molecules to the tooth surface. 
b) Passive transport of oral bacteria to the tooth surface. 
c) Co-adhesion of later colonisers to early colonisers which are already attached. 
d) Multiplication of attached microorganisms. 
e) Active detachment enabling colonisation elsewhere in the mouth. 
 
The process of plaque formation begins immediately after brushing and is initiated by 
the attachment of planktonic bacteria to the enamel (Kim et al. 2014). As plaque 
matures it is held within a matrix of polymers of salivary and bacterial origin (Pretty et 
al. 2005; Marsh 2004). This results in a complex community which accumulates 
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preferentially at stagnant sites which include proximal areas, gingival margins, 
margins of restorations, deep fissures and around orthodontic appliances (Pretty et 
al. 2005; Van der Veen et al. 2007). The biofilm has high levels of acidogenic 
(produce acid through fermenting carbohydrates) and aciduric bacteria (have the 
ability to resist the acid produced) which become more dominant with time (Kim et al. 
2014). As they accumulate and the plaque layer becomes thicker, the protective 
buffering and antimicrobial properties of saliva have less of an effect (Donlan & 
Costerton 2002).  
 
There are a number of different hypotheses which have aimed to identify the role of 
bacteria in caries. These include: 
 
1) Specific plaque theory: This theory proposes that only specific bacteria are 
the cause of dental caries in their production of acid. Therefore with this 
theory the aim is to tackle the specific bacteria in the biofilm (Miller 1980). 
 
2) Non – specific plaque theory: This theory proposes that the overall and total 
plaque biofilm is the cause of dental caries. Therefore with this theory the aim 
is to fully remove all the bacteria rather than focus on a specific one. This can 
be resolved by means of tooth brushing and mechanical plaque control 
(Loesche 1976). 
 
3) Ecological plaque hypothesis: This theory proposes that bacteria causing 
caries are on all the host sites. The cause of acid production and caries is due 
to change in the oral environment. If the sugar intake increases, this changes 
the oral environment leading the cariogenic bacteria to ferment the substrate, 
and release acid, demineralising enamel. Therefore in this theory the aim is to 
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not only tackle the bacteria in plaque, but create an environment which would 
reduce the risk of caries by controlling the environment (Marsh 1994). 
 
2.3 Carbohydrates/Diet 
 
The evidence available strongly suggests that carbohydrates and sugar consumption 
play a major role in the formation of caries. The evidence can be divided into 
intervention clinical trials, non-intervention and epidemiological studies. An example 
of the intervention clinical trials is the Vipeholm dental caries study (Gustafsson et al. 
1954). A total of 436 ‘mentally deficient patients’ were divided into groups to assess 
the effect of sugar in a number of different forms. The sugars were given at different 
time periods to assess how the rate of dental caries is affected by a) the amount of 
sugar, b) frequency of intake and c) the form of sugar. The groups included ones that 
were on a normal diet, high level of non-sticky sugars (that wouldn’t be retained on 
teeth), low level of sticky sugars and a high level of sticky sugars at different periods. 
The study concluded that: 
 
1) The increase in the number of sugars increases the risk of dental caries 
 
2) The sticky form of sugar that retained on teeth increased the risk 
 
3) The risk increases if the sugars are consumed between meals rather than 
during 
 
Although this study (conducted in the 1950s) is considered unethical, it has provided 
strong evidence to suggest the effects of carbohydrate intake, retention and 
frequency on dental caries (Gustafsson et al. 1954).  
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In the non-intervention clinical studies participants were mainly observed to assess 
the rate of caries in a population and its relation to their daily sugar intake. A study 
conducted in the UK looked at 405 English school adolescents’ daily sugar intake 
and assessed it in relation to the rate of caries. An annual dental examination was 
conducted with the use of radiographs to assess the rate of caries. The results 
showed a clear correlation between the total daily consumption of sugar and the rate 
of caries. Adolescents with the highest sugar intake developed a DMFS (decayed 
missing filled surfaces) score as high as 5.0 in compared with the ones that had half 
the amount of sugar intake with a DMFS of 0.9 (Rugg-Gunn et al. 1984). This non–
intervention clinical study gave further evidence to the amount of sugar intake and 
diet on the rate of dental caries. 
 
The epidemiological evidence in relation to the relationship between caries and 
sugar intake has been observed during times where the level of sugar availability 
was low. Severe dietary restrictions were evident in World War II, one of which was 
the availability of sugar. A reduction in the availability of sugar was accompanied by 
a decrease in the rate of dental caries in permanent teeth. The same concept of 
sugar availability was evident in Tristan da Cunha, where the locals had low caries 
rates which reflected the islands dietary habits; mainly low in sugar with the 
consumption of natural unprocessed foods. After the 1940s there was a clear 
increase in dental caries which reflected a shift in the rate of sugar intake following 
its importation (Holloway 1962). Another form of epidemiological evidence is with 
patients suffering from fructose intolerance disease. This rare hereditary disease 
forced patients to refrain from eating foods containing sucrose and fructose. These 
patients present with low caries rates which is a reflection of their low sugar intake.  
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With the evidence currently available looking at the amount of sugar consumption 
and the frequency of intake on caries levels, it is recommended that sugar intake is 
limited. This can be done by advising patients to reduce the amount of sugar intake 
or more practically reducing the frequency. Reduction in the frequency of intake 
would evidently reduce the amount of intake and the risk of caries in the long term 
(Prevention and Management of Dental Caries in Children SDCEP 2010). The 
maximum daily, safe limit for the amount of sugar intake has been set at 50g/60g 
(Sheiham 2001). In terms of the frequency of intake, it has been clearly 
demonstrated that an intake of sugar more than four times daily can have an 
increased risk of caries activity. This is particularly evident if patients intake sugar 
three times per day between meals (Holbrook 1995).  
 
As mentioned above there is a lot of evidence to support the reduction of sugar 
intake and the care needed in relation to the frequency of intake as well. The effects 
of sugar intake has been shown to have a positive linear correlation with caries. The 
effects on the type of sugar intake has also been demonstrated through the low pH 
oral environment that is created following sugar intake. The significant reduction of 
pH is thought to have a more important role in the development of caries than the 
intake of sugar (Marsh 1998). Though there may be a high sugar intake the effects 
on the dentition are very much dependent upon the oral environment created and the 
pH level. Therefore any aspects of the oral environment which may affect the pH can 
affect the caries risk. Behaviours such as tooth brushing, use of mouthwash or even 
water intake at a pH of 7 may alter the balance which can also reduce the effects on 
the enamel. The intake of foods such as cheese have been recommended by the 
SDCEP guidelines after sugar intake and meals (Prevention and Management of 
Dental Caries in Children SDCEP 2010). This is to ensure that a gradual increase in 
pH occurs away from the critical level. Though caution has been advocated to the 
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excessive consumption of foods which may also be high in calories and fat, such as 
cheese for general health purposes.  
 
The consumption of sugars such as sucrose is known to result in a pH reduction and 
a negative cariogenic environment is created if the pH falls below the critical level. 
This was demonstrated by Stephan (1944) showing a rapid reduction in the pH 
following sugar consumption (Figure 3). Within 2-3 minutes the pH can fall below the 
critical pH level. Time is needed for the pH to rise gradually in an oral environment 
with salivary buffering characteristics. The increased frequency of dietary sugars 
may maintain the pH at the critical pH level. This will prolong the cariogenic 
environment and prolong the effects on enamel which may lead to significant 
demineralisation.  
 
Figure 3 - Stephan curve outlining the effects of sucrose intake on pH levels 
(Stephan 1944) 
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2.4 Enamel/Host 
 
Dental enamel is largely inorganic, with 86-95% of its volume comprising of 
hydroxyapatite crystal of Calcium Phosphate (Ca10(PO4)6(OH)2) which is arranged 
in prisms. Pores are present due to inter‐crystalline spacing and this allows for the 
movement of ions between the enamel and the surrounding oral environment. The 
space can act as a pathway for diffusion which is an important factor in the 
development of dental caries (Robinson et al. 2000). 
 
The organic component is mainly composed of proteinaceous material (1-2% of the 
total volume), with water making up the remainder (Weatherell 1975). This 
proteinaceous material is formed of small peptides and amino acids distributed 
throughout the tissue. These are thought to be the remnants of the original 
developmental matrix which formed the tooth structure (Robinson et al. 2000). 
 
2.5 Demineralisation of dental enamel 
 
The demineralisation of tooth substance associated with plaque accumulation is a 
common unwanted occurrence during fixed appliance treatment (Atack et al. 1996). 
Fermentation of dietary sugars produces inorganic acids and results in 
demineralisation. The bacteria present in plaque lower the oral pH by producing 
acids which act to change the pH of the oral environment to below that of the critical 
level. This results in the dissolution of mineral content of the tooth (Chang et al. 
1997). The idea of a critical pH at which tooth demineralisation occurs, was 
represented in a curve produced by Stephan using data from a landmark in vivo 
study (Stephan 1944 – see Figure 3). 
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Most importantly, demineralisation is the first stage of dental caries and in the early 
stages this is reversible. When the pH is lowered below the critical level; calcium, 
phosphate and hydroxyl ions diffuse from the tooth into the surroundings. Reversal 
and remineralisation of tooth substance is aided mainly by the protective 
components of saliva, and fluoride found in toothpastes, mouthwashes, or drinking 
water. In the UK about 10% (6.1 million people) have drinking water with fluoride 
content sufficient enough to benefit oral health (1ppm fluoride). Of these, 5.8 million 
people receive artificially fluoridated water (British Fluoridation Society 2016). 
 
The carious process is episodic and an individual with an increased frequency of 
carbohydrate intake will have longer periods of low pH and thus more 
demineralisation may occur. If the rate of ion loss from enamel occurs at a greater 
rate than remineralisation, caries occurs. Caries then has the potential to advance 
through enamel and into dentine, destroying the tooth structure. 
 
The tooth demineralisation and remineralisation cycle which can occur during 
Orthodontic treatment is represented in Figure 4 above (Chang et al. 1997). This 
Figure 4 - Demineralisation and remineralisation during 
orthodontic treatment (Chang et al. 1997) 
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outlines the sequence of events and influencing factors which are often involved in 
the process. 
 
Microscopically dental caries has been divided into 4 zones in the literature 
depending on the degree of change in mineral content which can be seen when 
examined under polarised light. The original work of Darling (1963) was a new 
approach to analysing structural changes seen in caries by utilising polarised light 
and imbibition media to show changes in porosity as lesions progressed. These 4 
porosity related zones are defined as (Robinson et al. 2000; Darling 1963): 
 
1. Translucent zone: This is the deepest part of the carious lesion where the 
main ions affected are magnesium and calcium which are lost form the 
peripheral rod structures. There is a loss of about 1-2% mineral content and 
thus a small number of relatively large pores are present. 
 
2. Dark zone: This zone has both larger and smaller pores with an increased 
porosity of between 5-10%. In this portion more rods are involved than in the 
deepest zone. The mineral dissolution seen is mainly calcium and phosphate 
ions. 
 
3. Body of the lesion: The majority of the rods have been destroyed and porosity 
is high at between 25-50%. This is a destructive process in which the pores 
continue to increase in size until cavitation ultimately occurs. It is located just 
below the surface of the tooth. Rods have been replaced by bacteria 
surrounded by water. This area of lost mineral content may be seen clinically 
as a white spot on the tooth (hence the term ‘white spot lesion’ is often used). 
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With dietary or smoking related staining however this lesion may appear 
darkened or brown with time. 
 
4. Surface zone: This is the outermost layer which is dynamic with the mineral 
content fluctuating continuously depending on the oral pH. Despite this, 
changes beneath the surface zone may remain demineralised and an almost 
porous yet mineral rich layer can act to disguise a larger lesion below (Arends 
& Christoffersen 1986). 
2.6 Demineralisation classification 
 
There have been many indices designed with the aim of standardising the 
assessment of demineralisation and caries. Common examples of indices used to 
assess demineralisation of enamel include: 
a. International Caries Detection and Assessment System II (ICDAS II) which 
differentiates between cavitated and non cavitated lesions (Pitts 2004). It 
was also designed to allow for a better and more consistent assessment for 
cariological studies. 
Code Description 
0 Sound 
1 First visual change in enamel (seen after prolonged air drying) 
2 Distinct visual change in enamel 
3 Localised enamel breakdown (without clinical visual signs of dentinal 
involvement) 
4 Underlying dark shadow for dentine 
5 Distinct cavity with visible dentine 
6 Extensive distinct cavity with visible dentine 
Table 1 - ICDASII classification 
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b. This was then modified by the International Caries Classification and 
Management System (ICCMSTM) in which the basic ICDAS was merged to 
result in the following (ICCMSTM guide for practitioners and educators 
2014): 
Code Description  
Sound Surfaces 
(ICDAS 0) 
Sound tooth surface – show no 
evidence of visible caries when viewed 
clean and after prolonged air drying 
 
Initial stage caries 
(ICDAS 1+2) 
First or distinct visual changes in 
enamel – seen as a carious opacity or 
visible discolouration not consistent with 
the clinical appearance of sound enamel 
and which show no evidence of surface 
breakdown or underlying dentine 
shadowing. 
 
Moderate stage 
caries (ICDAS 3+4) 
A white or brown spot lesion with 
localised enamel breakdown, without 
visible dentine exposure or an 
underlying dentine show.  
Extensive stage 
caries (ICDAS 5+6) 
A distinct cavity in opaque or 
discoloured enamel with visible dentine. 
 
 
Table 2 - ICCMSTM classification 
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c. When categorising caries progression radiographs can be a very useful 
source of information. They can not only aid in assessing the presence or 
absence of caries but also the depth of caries. This becomes very useful in 
many situations such as areas that may not necessarily be clinically visible 
such as below the contact points. In many clinical cases where there is no 
evident cavitation, a radiograph may provide further evidence in relation to 
the presence and depth of caries. This will not only aid in caries diagnosis 
but also caries management. Therefore, a radiographic system was devised 
by ICDAS in which to stage caries radiologically. This staging system 
allowed for the assessment of the carious lesions to not only cover the basic 
levels of enamel, dentine and pulp but also divide these three layers. 
Furthermore, it combined the pulpal layer with clinical changes. This is 
evident in the table below (ICCMSTM guide for practitioners and educators 
2014): 
Scoring Description  
No 
radiolucency 
No radiolucency 
 
RA1 Radiolucency in the outer half of enamel 
 
RA2 Radiolucency in the inner ½ of enamel +/- 
enamel dentine junction 
 
RA3 Radiolucency limited to the outer third of 
dentine 
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RB4 Radiolucency reaching the middle third of 
dentine 
 
RC5 Radiolucency reaching the inner 1/3 of 
dentine, clinically cavitated 
 
RC6 Radiolucency into the pulp, clinically 
cavitated 
 
 
Table 3 - Radiographic ICDAS classification 
 
 
d. As with the visual caries staging in ICDAS the ICCMS merged the ICDAS 
radiographic stages in a system that has been shown to be reproducible 
and accurate (Pitts & Ekstrand 2013). See below: 
 
Scoring Description 
R0 No radiolucency 
RA – Initial 
stages 
Combining 
RA1 – outer 1/3 enamel 
RA2 – inner 1/3 of enamel +/- EDJ 
RA3 – limited to the outer 1/3 of dentine 
RB – Moderate 
stage  
RB4 – inner 1/3 of dentine 
RC – 
Extensive 
stages 
Combining 
RC5 – inner 1/3 of dentine, clinically cavitated 
RC6 – into the pulp, clinically cavitated 
 
Table 4 - Combined ICDAS, ICCMS and ICDAS radiographic 
classifications 
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e. Finally both the radiographic and clinical assessments were combined 
classifying the lesions into initial, moderate and extensive caries risk. The 
combination between the clinical and radiographic examination would aid a 
treating clinician to come up with a treatment plan which includes a 
preventative and definitive action (table 5) (ICCMSTM guide for practitioners 
and educators 2014):  
 R0 RA1/2 RA3 RB RC 
Sound 
 
Sound Initial Initial Moderate Extensive 
Initial 
 
Initial Initial Initial/ 
Moderate 
Moderate Extensive 
Moderate 
 
Moderate Moderate Moderate Moderate Extensive 
Extensive 
 
Extensive Extensive Extensive Extensive Extensive 
 
Table 5 - Combined ICDAS radiographic and clinical examination 
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f. Demineralisation can be categorised on a scale depending on the severity 
(Gorelick et al. 1982) in which tooth drying can allow for detection of white 
spot lesions. The general scale used by Gorelick was as follows: 
 
Score Description 
I No white spot formation 
II Slight white spot formation 
III Severe white spot formation (thicker band) 
IV White spot formation and 
cavitation 
 
Table 6 - Demineralisation according to severity by (Gorelik et al. 1982) 
 
 
g. Boyd and Rose (1994) assessed white spot lesions in combination with the 
clinical representation and a clinicians clinical judgement: 
 
Score Description 
0 No visible white spots or surface disruption 
1 Visible white spot without surface disruption 
2 Visible white spot lesion having a roughened surface 
3 Visible white spot lesion requiring a restoration 
 
Table 7 - Assessment of white spot lesions and its clinical 
representation (Boyd & Rose 1994) 
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h. Mizrahi (1982) devised a scoring system that divided the tooth surface into 
three distinct sections and assessed the extent of demineralisation 
accordingly: 
 
Score Description 
0 No enamel opacity, an opacity of less than 1mm in length or 
diameter (which was considered absent) 
1 An opacity covering upto one third of the surface area 
2 An opacity covering up one third to two thirds of the surface area 
3 An opacity covering up two thirds of the surface area 
 
Table 8 - Extent of demineralisation in segments in accordance with 
Mizrahi 1982 
  
In the scoring systems above there is a clear emphasis on the clinician’s clinical 
examination in an aim to screen for caries lesions. This has a number of 
advantages and disadvantages. Its advantages is that it is a very simple and 
inexpensive method with minimum tools needed. Though the main disadvantages 
is that using simple clinical examination methods means that the assessment is 
subjective. The scoring systems above are mainly descriptive as well and rarely is 
there an accurate quantification. The layer of enamel is very thin and to assess a 
radiolucency by dividing that thin layer in half may be considered unreliable. 
Reliability and reproducibility is key when using scoring measures for research. 
The inability to reproduce a measure poses questionable outcomes to any 
research. 
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2.7 Plaque stagnation and Orthodontic treatment 
 
In Orthodontics, the use of fixed appliance components such as bands, brackets and 
archwires lead to an increase in plaque accumulation mainly at the gingival margins 
(Van der Veen et al. 2007). In addition, the teeth are also more challenging to clean, 
which together with the reduced natural clearance of plaque by saliva, acts to compound 
plaque retention (Mattousch et al. 2007). The greater the complexity of appliance 
components, the more difficult it is for a patient to clean adequately (Zachrisson & 
Zachrisson 1971). When compared with traditional caries formation, the rate of 
caries progression is reported to be faster around fixed appliances. Early caries 
(white spot demineralisation) can present within 4 weeks of appliance placement 
(Ogaard & Ten Bosch 1994). 
 
The cited prevalence of demineralisation during Orthodontic treatment varies greatly 
in the literature with data reported between 2-96% (Gorelick et al. 1982; Mizrahi 
1982; Ogaard 1989). This variation of prevalence in studies was mainly due to the 
different methods of assessing white spot lesions, and the lack of standardisation 
between studies. For example, enamel abnormalities such as fluorosis or hypoplasia 
may be documented as a white spot lesion leading to a false positive finding. Also, a 
thorough pre-treatment examination must be completed so pre-existing areas of 
demineralisation are not mistaken for areas which have developed during 
orthodontic treatment. 
 
In 1982, Mizrahi completed a cross sectional study of patients undergoing 
multibanded fixed appliance orthodontic treatment (Mizrahi 1982). In this study, 
demineralisation was assessed using the opacity index, and it showed a 12% 
increase in the number of white spot lesions in the patients undergoing orthodontic 
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treatment. The relevance of this in today’s clinical practice however is questionable, 
as multibanded fixed appliances are no longer commonly prescribed. In 1989, 
Ogaard compared a group of patients whom had received fixed Orthodontic 
treatment (on average they were debonded 5.7 years prior to data collection), with a 
group of untreated controls. The median of white spot lesions was significantly 
higher in the orthodontically treated group compared with the untreated group 
(p=<0.01). There was no significant difference in white spot occurrence between 
males and females, upper and lower arches, or between left and right sides (Ogaard 
1989).  
 
The use of Quantitative Light Induced Fluorescence (QLF) in a study by Al-Maaitah 
(2011) found the prevalence of demineralisation to be 71.7%. This was higher when 
compared with a 29.7% (p < 0.001) prevalence at debond, reported in the placebo 
group (in a randomised control trial) of Orthodontic patients using digital images 
(Stecksttén-Blicks et al. 2007). It is difficult to compare the results of studies that use 
different means of recording and quantifying the amount of plaque and/or white spot 
lesions. The fact that demineralisation is a well-recognised potential complication of 
treatment means that patients must be made aware of the risks of white spot lesions. 
During the consent process before treatment this must be made very clear. Different 
strategies need to be discussed as well to avoid demineralisation if they are to be 
satisfied with the post orthodontic results. Teeth may be straight with an adequate 
occlusion, though the aesthetic and dental health outcomes may be compromised 
with the presence of demineralisation. This is particularly concerning to patients 
when in the anterior smile zone. 
 
Demineralisation can affect any tooth surface, but some areas appear to be more 
prone than others. The maxillary lateral incisors are most frequently reported to 
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demonstrate white spot lesions following Orthodontic treatment, followed by the 
maxillary canines, premolars and central incisors respectively (Chapman et al. 
2010). Gorelick et al. (1982) reported the incidence of white spot lesions in lateral 
incisors are as high as 23%. This was concluded following an assessment of 121 
Orthodontic patients. This increase may be due to several factors including (Ogaard 
1989): 
 
 Bracket positioning being closer to gingival margin.  
 Morphology of the lateral incisor itself. 
 Tendency of the lateral incisor to be displaced palatally making it more 
challenging to remove plaque in the early stages of fixed appliance 
treatment. 
 
Fixed appliance treatment has been documented to negatively impact tooth cleaning 
and may result in the formation of chronic hyperplastic gingivitis in some cases. 
Plaque is the main causative factor of chronic hyperplastic gingivitis, but this 
condition is also greatly influenced by environmental and genetic factors (Atack et al. 
1996). An important aspect to question is whether Orthodontic appliances, by 
increasing plaque stagnation, may influence the progression from gingivitis to 
periodontitis (Anhoury et al. 2009). 
 
Changes due to plaque retention can be permanent. It is essential that Orthodontic 
patients demonstrate their ability to maintain excellent oral hygiene both before and 
during treatment. Methods of detecting early signs of demineralisation are likely to be 
a very useful tool for both clinicians and patients alike. This helps to limit progression 
of the demineralisation and potentially reduces the risk of further lesions occurring. 
Therefore, patients need to be informed of the consequences related to poor oral 
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hygiene and the methods in which the incidence of white spot lesions can be 
reduced.  
2.8 Patient information 
 
It is thought that no single method of instruction will suit all learners equally (Yoder 
1994). Previous literature in medicine and dentistry has commonly provided patients 
with information in verbal (chair-side), written or videotape form (Lees & Rock 2000). 
Of these, written instructions alone is thought to be the least effective (Self et al. 
1983). Lees and Rock (2000) conducted a clinical trial comparing the effect of verbal, 
written or videotape oral hygiene information using knowledge, plaque and gingival 
indices as outcomes. Although the results did not reach a level of significance, there 
was greater improvement in the oral hygiene of patients in both the verbal and 
videotape groups. Those who received only written instructions demonstrated no 
improvement in their plaque index. This study was prone to multiple biases including 
the use of a single examiner, and outcomes were only tested on two occasions 
(once before information being given, and the second time 8 weeks later). At both of 
these appointments plaque, gingival indices and knowledge were all examined. 
 
2.9 Oral health promotion 
 
In a systematic literature review of randomised and quasi-randomised controlled 
clinical trials, Grey and McIntyre (2008) assessed the effects of oral health promotion 
programs on plaque and gingival health. They concluded that oral health promotion 
programmes for Orthodontic patients were beneficial in reducing plaque and 
improving gingival health. This was over a short term period of 5 months. They also 
reported that based on the available evidence, no method of oral health promotion 
appeared to be superior to the others. Verbal advice from a health care professionals 
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along with a plaque disclosing programme has been reported in the literature to 
reduce plaque levels when compared to verbal instruction alone (Gray & McIntyre 
2008). 
 
Health education has been recommended to be part of a continuous process rather 
than part of a single episode to gain optimal outcomes (Talvi et al. 1999). Marinho et 
al. (2003) in a Cochrane Review outlined the benefits of fluoride toothpastes 
demonstrated in numerous trials as part of health education programs. Clinical 
studies support the use of a 0.05% sodium fluoride mouthwash on a daily basis 
during Orthodontic treatment as part of an oral health program (Boyd & Rose 1994). 
 
2.10 Plaque and demineralisation identification 
 
In this section the various methods of assessing oral hygiene status and in particular 
methods of plaque and demineralisation identification will be demonstrated. This will 
include direct visual assessment, plaque disclosure and photography. More recent 
diagnostic tools have also been developed including Quantitative Light Induced 
Fluoresce (QLF), Quantitative Light Induced Fluorescence - Digital (QLF-D), 
DIAGNOdent, Toothcare and Q-Scan which are available for use in a chair-side 
setting. These will also be discussed in detail in an aim to summarise the latest 
advancements in the field of plaque and demineralisation identification. 
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2.10.1 Direct visual assessment 
 
In order for individuals to clean their mouth effectively they need to be able to identify 
plaque, and in particular, to note the problematic areas which are inherently more 
prone to its collection (Pretty et al. 2005). Large amounts of plaque are quite easily 
visible to the naked eye, but smaller amounts in shadowed areas and around 
appliances can be more difficult to visualise directly. 
 
Direct visual assessment is the most common method to assess the presence of 
dental plaque and there are several indices which enable the clinician to quantify the 
amount present. Depending on the study, plaque may be quantified by the amount of 
tooth surface covered, or by the thickness of the plaque in the area measured (Pretty 
et al. 2005). Some examples of these methods include: 
 
i) The Greene and Vermillion article (1960) was a landmark piece of literature 
discussing a method for classifying oral hygiene status. This plaque index 
may be used with plaque disclosing tablets. The tooth is divided into 
horizontal and vertical thirds leaving the orthodontic bracket in the centre. In a 
study by Lees and Rock (2000) they used the 5 boxes gingival and directly 
alongside the bracket to quantify the amount of plaque present. 
 
ii) The Modified Ramfjord Index uses the facial and lingual surfaces of 6 
selected teeth and assigns a score between 0-3 depending on the amount of 
tooth substance covered by plaque (UR6, UL1, UL4, LL6, LR1 and LR4). The 
total score is divided by the number of surfaces to give a mean (Ramfjord 
1967; Shick & Ash 1961). 
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iii) The Quigley and Hein plaque index (1962), involves disclosing plaque and 
scoring 0-5 depending on the amount of tooth surface (buccal and lingual) 
with plaque present. The mean score is established by dividing this by the 
number of tooth surfaces (Pretty et al. 2005; Quigley & Hein 1962). 
 
iv) The Loe and Silness index (1963) examines the thickness of plaque rather 
than the extension of plaque on the tooth surface. It can be used with or 
without plaque disclosing agents. Each of the 4 gingival areas of a tooth are 
scored 0-3 (Loe & Silness 1963): 
 
0- No plaque. 
 
1- A film of plaque adhering to gingival margin and adjacent area of the 
tooth. Plaque may be seen in-‐‐situ only after application of disclosing 
solution or by using a probe on the tooth surface. 
 
2- Moderate accumulation of soft deposits within the gingival 
pocket, or on the tooth and gingival margin which can be seen 
with the naked eye. 
 
3- Abundance of soft matter within the gingival pocket and/or on 
the tooth and gingival margin. 
 
v) In addition to these methods, the Bonded Bracket Plaque Index (Kiliçoğlu et al. 
1997) is specifically designed to assess plaque accumulation during fixed 
Orthodontic treatment. This index classifies plaque based on location and extent 
of coverage on the bracket and tooth: 
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1. No plaque on bracket or tooth surface. 
2. Plaque on bracket. 
3. Plaque on bracket, tooth, no extension to gingiva. 
4. Plaque on bracket, tooth, extension to papilla. 
5. Plaque on bracket, tooth, partial coverage to gingivae. 
6. Plaque on bracket, tooth, full coverage to gingivae. 
 
 
Interestingly, although this index is specifically designed for use in Orthodontic 
patients, the Loe, Silness and Turesky indices (Turesky et al. 1970) are more 
frequently used. They are reported to be a reliable means of quantifying plaque 
coverage. In general, the method of plaque detection selected for research is 
dependent on several factors including (Pretty et al. 2005): 
 
 Type of research  
 Population included 
 Facilities available 
 Duration of the project 
 Research question 
 Specific changes which are to be measured 
 
In a clinical scenario, the most common method for plaque identification is a simple 
visual assessment. Issues with reported low sensitivity and specificity of plaque 
scoring systems have been addressed to a certain extent by calibrating examiners in 
the assessment process. This calibration however, increases the cost of the 
research and does not necessarily address the validity of the findings. More 
precision and better sensitivity is seen with QLF which has the ability to detect even 
very small amounts of plaque (Cugini et al. 2006). 
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2.10.2 Plaque disclosure 
 
Plaque is generally colourless. In clinical fields, disclosure is a simple way for the 
clinician and patient to see the plaque present chair-side. This can then be used as a 
guide to improve brushing technique (Figure 5) (Faller 2000; Pretty et al. 2005). 
Disclosing tablets often contain erythrosine dye which stains the areas of concern 
red demonstrating the plaque distribution. This method is useful for educational 
purposes and patients can use the disclosing tablets themselves at-home. Issues 
include potential patient discomfort during disclosure, staining, time implications 
clinically inconveniencing the operator and the patient if done in the clinic, and 
reported occurrences of allergies. It is also important to note that this using 
disclosing tablets doesn’t allow for the assessment of the pathogenic status of 
plaque (Kim et al. 2014). 
 
Fluorescein disclosing can be completed using a UV fluorescent dye that is 
colourless when applied but adheres to plaque. A digital image is obtained, and 
using the fluorescence a digital plaque analysis can be completed. This is thought to 
be a good means of quantifying the amount of plaque present, however it is relatively 
costly (Pretty et al. 2005). 
Figure 5 - Plaque discosure using diaclosing dye (Pretty 
et al. 2005) 
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2.10.3 Photography 
 
Digital photography is now an integral part of Orthodontic assessment, diagnosis, for 
monitoring treatment progress, and documenting treatment from start to a final 
result. It is a reproducible and valid means of measuring the quantity of dental 
plaque on tooth surfaces (Rosa & Elizondo 2015). Sandler and Murray (2002) 
following a survey of Orthodontists in Europe recommended the minimum number of 
photographs for an Orthodontic patient to be 9 pre and 9 post-treatment. This can be 
divided in to 4 extra-oral (frontal at rest, frontal smiling, profile and three-quarters) 
and 5 intra-oral (frontal, buccal right and left, occlusal upper and lower). However, 36 
photographs are thought to be required to ensure the course of treatment is 
documented comprehensively. 
 
Photographs act as an efficient, cost effective and permanent means of recording 
patient information (Benson et al. 1998). The information can be easily stored and 
analysed at a later date, which is useful in research when observer recall bias can be 
reduced by completing inter-examiner assessments. Some disadvantages include 
difficulties in achieving consistency in relation to magnification, lighting and 
angulation of the images making it challenging to compare data and to assess 
progress accurately (Benson et al. 2004). The analysis of digital photographs has 
also been reported to be a valid and reliable method of quantifying demineralisation 
(Benson et al. 2003a). Further improvements on white light digital photography has 
been established in an aim for a more accurate assessment and analysis of plaque 
and caries detection. 
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2.10.4 Quantitative light induced fluorescence (QLF) 
 
Quantitative light induced fluorescence (QLF) is a non-invasive diagnostic tool which 
allows for the quantification of enamel demineralisation, incipient carious lesions on 
smooth surfaces and the accumulation of dental plaque using visible fluorescent light 
(De Josselin De Jong et al. 1995; Angmar‐Månsson & Ten Bosch 2001). The 
diagnostic capacity of QLF is dependent on the 
mechanism that the natural fluorescence (auto-
fluorescence) of a tooth is decreased by scattering 
which occurs in carious lesions (demineralised 
tooth substance) (Angmar‐Månsson & Ten Bosch 
2001; Van der Veen et al. 2007). QLF can be 
used to calculate the severity of demineralisation 
by quantifying the size of the lesion and/or the 
extent of mineral loss in the affected area 
(Benson et al. 2003a). It has been shown to be a valid, sensitive and reproducible 
means of detecting early caries and for monitoring lesion progression (Stookey 
2004). 
Other methods using fluorescence have involved lasers or ultraviolet light, however 
because of potential eye damage these are deemed inappropriate in a clinical setting 
(Benson et al. 2003a). A portable QLF system was developed and first manufactured 
by Inspektor Research Systems in Amsterdam; it consisted of a charged couple 
device camera, filters and light sources which were connected to a computer (Figure 
6, 7) (Al-Khateeb et al. 1997). The QLF images obtained were stored to allow for 
customised software analysis of the fluorescence levels present (Van der Veen et al. 
2007). Heavy mature deposits of plaque appeared a deep red colour and were 
referred to as red fluorescent plaque (Sadeq et al. 2015). This red fluorescent plaque 
Figure 6 - QLF diagnostic 
system 
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(Figure 8) was thought to be red due to the presence of bacterial porphyrins present 
mainly in gram-negative anaerobes. The auto-fluorescence of these bacterial 
porphyrins (which are by-products of bacterial metabolism), means that both plaque 
and dental caries appear red using QLF images (Figure 8). The red colour is easier 
to identify in a more mature biofilm as a greater number of bacterial species are 
present. Hence, it can be suggested that the more intense the red is seen on the 
image, the higher the bacterial activity and thus the possibility of greater 
pathogenicity. 
 
 
Figure 7 - The portable QLF diagnostic system (Al-Khateeb et al. 1997) 
 
 
 
 
 
 
 
 
 
 
Figure 8 - Appearance of undisclosing plaque under QLF conditions (Han et al. 
2015) 
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Plaque accumulation is graded using the customised QLF software according to 
amount of tooth coverage, which is based on the amount of red colour seen at 
various cut off points. The value of ∆R is representative of how many pixels are 
covered by red fluorescence. The fluorescence loss in the lesions is assessed 
relative to the surrounding enamel, therefore the outline of the analysis needs to be 
based on sound enamel to reduce the occurrence of false positives. Areas with 
fluorescence loss of over 5% are deemed part of the demineralised lesion (Pretty et 
al. 2003). Mean fluorescence loss is represented by ∆F which is determined by the 
level of demineralisation and the size of the lesion (∆Q), it is based on the number of 
pixels involved (Pretty et al. 2002). QLF has been shown to be a valid and reliable 
tool for assessing plaque accumulation in vivo (Pretty et al. 2005) and in vitro 
(Benson et al. 2003a; 2003b).  
QLF allows for plaque and demineralisation to be monitored more precisely than 
when descriptive indices are used (see section 2.10.1) and it detects 
demineralisation at an earlier stage than visual inspection or white light. Areas with 
greater than 15% fluorescence loss have been reported to be visible clinically 
(Boersma et al. 2005). The early detection of problems using QLF allows the 
clinician to reinforce oral hygiene and if 
appropriate to encourage 
remineralisation strategies. 
2.10.5 Quantitative Light Induced 
Fluorescence-Digital Biluminator 
(QLF-D) 
 
This is an updated version of the 
original QLF device which examines 
plaque more clearly (Lee et al. 2013). 
 
Figure 9 - QLF-D camera and system 
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It was designed to enhance the features of the original system (Figure 6) and has a 
modified filter set and an enhanced light source (Ko et al. 2015). It is composed of a 
single-lens flex camera (SLR) attached to a laptop computer system with an 
automatic photo uploading system (Figure 9). The SLR camera has a built in 
extension which includes white and blue light emitting diode LED lights (Figure 10). It 
allows for automatic white light and blue light images to be taken.  It still uses the 
principle of auto-fluorescence of teeth. When visible blue light of 405nm is emitted 
from the device there’s a loss of fluorescence in the areas which have been 
demineralised. It is also designed to detect endogenous porphyrins which are 
represented as red fluorescence. It is thought to provide a clearer image of red 
fluorescence and to provide high resolution images when compared with the 
previous QLF system, (Kim et al. 2014) without the need for ambient light (Lee et al. 
2013). The QLF-D was validated as a means of approximal caries identification in an 
in vitro study by Ko et al. in 2015. In that study it was shown to have high intra-
examiner reliability, however the research did 
rely on one examiner for all methods. In 
addition to this the study was done in vitro 
resulting in the data lacking generalisability. 
 
Figure 10 - White and Blue LED 
lights to take both white light 
photographs and QLF 
photographs (Blue arrow 
representing the blue LED and 
the white arrow representing 
white LED) 
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A recent study was conducted with an aim to 
assess the detailed analysis of QLF-D. It 
aimed to assess the mean fluorescence loss, 
the maximum fluorescence loss, the lesion 
area and the lesion volume following 
orthodontic treatment. The aim was to place 
fluoride varnish (0.1% fluoride) on the white 
spot lesions and assess whether the QLF-D 
system would be able to detect the subtle 
changes following remineralisation. The 
authors concluded that the system was very 
sensitive to the small levels of mineral changes. Unfortunately this paper was 
considered as a pilot study with a small sample size, and used a technique that is 
not often practiced. The immediate fluoride varnish application may limit the 
reduction of the lesions volume and size. The study was simply used to show a 
reduction and change in demineralisation though no evidence in the validity or 
reliability of the change seen. There was also no comparison to any other measures 
of demineralisation detection (Kang et al. 2017). 
The gold standard form of demineralisation detection and assessment is with the use 
of transverse microradiography (Ten Bosch et al. 1991) (Figure 11). This has been 
assessed in relation to the use of QLF-D in vitro. A study conducted by Cochrane et 
al. (2012) aimed to assess these changes following an in vitro lesion formation and 
remineralisation detected by the use of QLF-D and transverse microradiography. 
The results showed that there was an evident correlation between the use of QLF-D 
and transverse microradiography. Therefore in comparison to the gold standard 
QLF-D showed promising results of detection. This however was conducted in vitro 
and mounting curved crowns in a lab based setting with the detection systems is a 
 
Figure 11 - Transverse 
microradiography system 
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very delicate process. Previous research has shown that this occasionally results in 
glaring due to the curvature of the crowns, which results in areas of high reflectance 
and non-uniform reflectance. This can directly affect the outcome and detection 
levels.   
 
QLF-D has also been shown in vitro to differentiate between early and more mature 
plaque as fluorescence intensity increases with maturity of the biofilm (Kim et al. 
2014). Other research papers have reported that QLF‐D can determine the 
cariogenicity of biofilms by assessing the intensity of red fluorescence (Lee et al. 
2013; Kim et al. 2014). The severity of demineralisation was significantly correlated 
with biofilm maturation levels. Therefore, identification of these areas and 
investigation of preventive methods and increased patient motivation, possibly has 
the potential to halt the cariogenic process. This particular study used bovine enamel 
which is thought to be an acceptable comparison for human tooth enamel (Kim et al. 
2014). 
 
2.10.6 DIAGNOdent pen (KaVo, Biberach, Germany) 
 
The DIAGNOdent pen (Figure 12) uses a laser light (655nm wavelength) to 
illuminate the tooth surface and detect dental caries. Normal healthy tooth substance 
demonstrates little fluorescence. In each person the score will be different so the pen 
must be calibrated using each individuals healthy tooth structure as a reference. As 
the teeth are examined, any area with greater bacterial activity will demonstrate 
more fluorescence, a higher pitched frequency will be produced and the number on 
the dial will be elevated. Hence it’s a simple, chair-side, non-invasive means of 
differentiating between carious and healthy tooth substance. The fluorescence is 
readily quantified and represented as a number displayed on the panel of the device 
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itself (Shi et al. 2001). This means there is reduced operator input and thus less 
potential for operator bias. Studies in vitro have reported the DIAGNOdent as 
effective in detecting smooth surface caries (Shi et al. 2001) and demineralisation 
adjacent to Orthodontic fixed appliances (Staudt et al. 2004). 
 
 
Figure 12 - DIAGNOdent pen (Kavo dental 2019) 
 
 
2.10.7 Toothcare (All In One Bio Inc, Seoul, Korea) 
 
Toothcare is similar to QLF (see 2.10.4) as it also allows for the detection of both 
plaque and demineralisation. It’s a handheld device which uses a 450nm light-
emitting diode (LED) to illuminate the tooth surface with a blue light. Filters may then 
be used resulting in green and red fluorescence which filter the yellow and red light 
with transmission peaks of 500-630nm. This instrument is very useable chair-side as 
it is compact and relatively inexpensive. The main disadvantage is that unlike QLF, 
there is no means of directly quantifying the plaque or demineralisation levels and 
thus descriptive indices are used, resulting in an increased potential for bias during 
attempts at quantification. 
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2.10.8 QScan Device (Inspektor Technology, The Netherlands) 
 
See Appendix 2 for detailed images of QScan device. 
See Appendix 3 for instructions on how to use the QScan device at home. 
 
The Q‐Scan oral hygiene device (Figure 13) is 
a Conformité Européenne (CE) approved hand 
held device which incorporates QLF technology 
to enable fluorescent plaque examination. The 
device illuminates the mouth using blue light 
and filters which can identify plaque and white 
spot lesions. QScan can allow the identification 
of more mature and potentially damaging 
plaque without the need for using dyes or 
disclosing agents, which can be time 
consuming and stain the oral soft tissues 
temporarily. It is specifically designed to allow 
patients to check their oral health status at-
home. The battery lasts for 120 minutes and takes an hour to charge optimally. This 
means the device will need to be re-charged relatively infrequently. The developers, 
Inspektor Technology, report its advantages to include: 
 
i. No additional equipment required. 
ii. Easy to use for people without clinical experience. 
iii. Easy to use both in a clinical and non-clinical setting. 
iv. Uses rechargeable batteries. 
 
Figure 13 - QScan Device 
(Inspektor Technology) 
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However, the device does not allow for the recording of photographs or videos, or for 
the analysis of plaque present, but it is hoped to be of particular benefit to 
Orthodontic patients to highlight any plaque left behind after cleaning. 
There are many local factors that have been established to cause the accumulation 
of plaque which may lead to periodontal disease. The presence of faulty restorations 
and overhangs can accumulate plaque which is also the case with badly designed 
partial dentures.  Orthodontic appliances have also been stressed as a local factor 
which causes the accumulation of plaque (Van der Veen et al. 2007). Whether it is the 
specific, non-specific or unified theories that are addressed, adequate oral hygiene is 
key especially in situations where local factors may make the removal of plaque 
more challenging.   
A recent study oral health education program was conducted using the QScan 
device in an aim to educate school children on the importance of adequate oral 
hygiene. One hundred adolescents were divided into two groups in which one group 
was provided with traditional oral hygiene instructions and the experimental group 
was provided with QScan device based learning. The authors concluded that the use 
of QLF based learning resulted in a significant improvement of oral hygiene in the 
participants compared to the control group. However this was over an 8 week period 
which is a short period of assessment. In addition there is a risk of the Hawthorne 
effect with school children in the same school divided into two groups (Khudanov et 
al. 2018).   
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2.11 Plaque and periodontal disease: 
 
It has been well documented that one of the primary cause of periodontal disease is 
bacteria. Studies have concluded that there is an increase in the number of bacteria 
present in inflamed gingivae when compared to an area of stable periodontium (Eley 
2010). This was also evident when assessing the number of bacteria in the oral 
cavity with patients presenting with periodontal disease. In an experiment conducted 
by Loe (1965) 12 students were asked to refrain from the use of oral hygiene 
measures.  This resulted in the accumulation of plaque around the gingivae and 
gingival inflammation was evident in all of the students. For completion, the students 
then returned to their normal oral hygiene routine reducing the accumulation of 
plaque which drastically improved their periodontal status.  
There has been much debate about the aetiology of periodontal disease. The main 
theories proposed are the specific theory, the non-specific theory and the unified 
theory. The ‘specific theory’ states that there is a specific pathogen that causes 
periodontal disease. This theory follows the single pathogen concept in diseases 
such as typhoid and tuberculosis. Therefore, if this specific pathogen is eliminated 
then periodontal disease is controlled (Loesche 1979). The ‘non-specific theory’ 
states that the inflammatory process of periodontal disease occurs when the 
pathogens exceed the threshold of host resistance. Therefore, in this theory the 
concept of total plaque control is key to ensure the control of gum inflammation and 
in severe cases, periodontal disease (Theilade 1986).  The ‘ecological theory’ states 
that periodontal disease is triggered when an imbalance occurs between the 
environment and the microflora (Marsh 1994). There is evidence to support that 
specific bacteria are present in severe cases of gum disease such as Prophomonas 
Gingivalis, Prevotella Intermedia, Bacteroides forsythus, Fusobacterium Nucleatum 
and A. Actinomycetecomitans. These bacteria have been associated with 
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periodontal disease and are seen in sites with attachment loss and inflammation. 
Regardless of which theory is applied in relation to the aetiology of periodontal 
disease, one must emphasise the importance of adequate oral hygiene. Plaque 
control would ensure maintaining a stable periodontium (Walker 1979, van 
Winkelhoff et al 2002).  
2.11.1 Indices of periodontal disease: 
 
The most common indicies are the gingival index and the bleeding on probing index. 
The gingival index focusses on the severity of the condition on a scale of 0-3. The 
mesial, buccal, distal and lingual gingival units are scored separately as follows: 
Gingival Index (Loe and Silness 1963):  
Normal gingivae 
0- Mild inflammation, slight change in colour, slight oedema and no bleeding on 
probing 
1- Moderate inflammation, redness, oedema and glazing. Bleeding on probing 
2- Severe inflammation. Marked redness and oedema, ulceration. Tendency on 
spontaneous bleeding. 
The Bleeding on probing index uses the same areas of assessment for all the teeth 
and also a scale from 0-3 as follows: 
Bleeding on Probing Index (Loe 1967): 
0- Normal gingivae 
1- Signs of gingival inflammation but no bleeding on gentle probing 
2- Bleeding on probing 
3- Spontaneous gingival bleeding 
The two indicies above mainly assessed areas for gingivitis rather than periodontitis. 
The main periodontal destruction indices used are the periodontal index         
(Russell 1956), the periodontal disease index (Ramjford 1959) and the community 
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periodontal index of treatment needs (CPITN) developed by Ainamo et al. (1983). 
The CPITN has been known as the most widely used system due to its ability to 
integrate the treatment need in a community setting (British Society of 
Periodontology - The good practitioner’s guide to periodontology 2016). The dentition 
is divided into six sextants and coded depending on the score using a specially 
banded probe known as the basic periodontal examination probe. The scores are as 
follows:  
 
Score Description 
0 No pockets >3.5 mm, no calculus/overhangs, no bleeding after probing (black 
band completely visible) 
1 No pockets >3.5 mm, no calculus/overhangs, but bleeding after probing (black 
band completely visible) 
2 No pockets >3.5 mm, but supra- or subgingival calculus/overhangs (black 
band completely visible) 
3 Probing depth 3.5-5.5 mm (black band partially visible, indicating pocket of 4-
5 mm) 
4 Probing depth >5.5 mm (black band entirely within the pocket, indicating 
pocket of 6 mm or more) 
* Furcation involvement
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The codes are clinically related to recommended treatment plans which are as follows: 
 
Score 
 
Description 
 
0 
 
No need for periodontal treatment 
 
1 
 
Oral hygiene instruction (OHI) 
 
2 
 
As in code 1, OHI, removal of plaque retentive factors, including all supra- 
and subgingival calculus 
 
3 
 
As in code 2, OHI, root surface debridement (RSD) 
 
4 
 
OHI, RSD. Assess the need for more complex treatment; referral to a 
specialist may be indicated. 
 
* 
 
To be treated according to BPE 0-4, OHI, RSD. Assess the need for more 
complex treatment; referral to a specialist may be indicated. 
 
Table 9 - Treatment recommendations related to the BPE scoring system (British 
Society of Periodontology - The good practitioner’s guide to periodontology 2016) 
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Separate plaque indices have also been established to assess plaque accumulation.  
This index developed by Loe and Silness (1963) is rarely used alone and it is usually 
used alongside the gingival index to assess causal relationship. The plaque index is as 
follows: 
 
Plaque index (PI): 
0- No plaque 
1- Film of plaque visible only by removal on probe or by disclosing  
2- Moderate accumulation of plaque which can be seen by the naked eye 
3- Abundance of soft matter within the gingival pocket and/or on the tooth and 
gingival margin 
 
These indices have clear limitations which must be taken under consideration when 
used in research. The scores may be very subjective with various terminologies used 
such as redness, slight redness and marked redness. They are also subjective in 
relation to the degrees of inflammation and pocket depth. In a number of these indicies 
the pocket depth is mainly assessed to provide a score. Pocket depth may be an 
assessment of past disease and not current disease, especially when there is no 
bleeding. Furthermore, the absence of bleeding on probing may be established as the 
presence of a stable periodontium though the presence of bleeding may not necessarily 
indicate the presence of disease (Lang et al. 1990). Nevins (1989) pointed out that 
bleeding on probing has a predictive ‘disease activity value’ of no more than 30%. At 
times bleeding on probing occurs due to the excessive force applied by the examiner, 
which effects the true representation of disease activity in the area. Therefore these 
indices must be used with caution due to the evident limitations associated with them.  
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2.12 Adjuncts to oral hygiene instructions  
2.12.1 Behavioural management 
 
One of the major clinical adjuncts to improving patient’s oral hygiene is behavioural 
management which can be done in a clinical setting (British Society of Periodontology - 
The good practitioner’s guide to periodontology 2016). This would not only aim to 
ensure patients comply with the advice given, but also to ensure consistency in their 
behaviour. The Department of Health in England released a toolkit in 2017 for general 
dental practitioners titled ‘Delivering better oral health – an evidence based toolkit for 
prevention’. This toolkit covered the main aspects of behavioural management in 
regards to OHI. It provided evidence based techniques to general dental practitioners to 
further develop their understanding of behavioural management. The main role of dental 
practitioners in promoting behavioural change and maintaining it was described in a 
cycle which focussed on (Figure 14): 
1) Deciding on the message – providing the patient with clear and concise 
information which is personalised to their circumstances. 
2) Ensuring effective communication using various methods – active listening, open 
questions, motivational interviewing, using non-verbal communication etc. 
3) Goal setting by using ‘SMART’: 
a) S – Specific – clear and precise goal set and clarified 
b) M – Measurable – a goal which can be measured and quantified 
c) A – Achievable – set a goal within a patients reach and achievable. Goals 
which are unachievable may demotivate the patient 
d) R – Relevant – has to be relevant to patients circumstances of they will not be 
motivated enough to stick to the behaviour 
e) T – Timely – the timing is right at the moment to achieve the goal with a clear 
timeframe 
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4) Monitoring progress – supporting the behaviour change and encouraging patients 
to continue doing so 
5) Sign posting – ensuring to repeat and warn patients when needed 
 
2.12.2 Manual toothbrush and the electric toothbrush 
 
One of the most frequently asked questions patients in relation to oral hygiene is in 
regards to toothbrush use. The type of toothbrush has always been an area of debate. 
Manual tooth brushing has been established as an adequate measure to reducing 
plaque and ensuring adequate oral hygiene. Various techniques have been proposed to 
ensure adequate brushing techniques such as the roll technique, bass, modified bass, 
Stillman’s, vertical, Charter’s and scrub brush. These techniques aim to ensure 
adequate plaque removal in a straightforward fashion with minimal long-term damage to 
the gingivae (Eley 2010).  
 
Figure 14 - Behavioral managment cycle for patient 
compliance (Public Health England - Delivering better oral 
health - an evidence based toolkit for prevention 2017) 
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Patients are usually overwhelmed with the number of choices in regards to manual 
toothbrushes. Therefore dentists are encouraged to guide patients with regards to the 
basics needed for a manual toothbrush which includes (Prevention and Management of 
Dental Caries in Children SDCEP guidelines 2010): 
1) Small head with a length of about 2.5cm for an adult to ensure reaching all 
areas in the mouth 
2) Bristles should be of even length so that they may act simultaneously 
3) Soft to medium soft stiffness to ensure no damage to hard or soft tissue 
4) Brush should be easy to clean 
5) Handle must be comfortable to hold and manipulate  
 
Many studies have now been published on the subject of manual vs electric 
toothbrushes. Some studies have concluded that electric toothbrushes have no added 
benefit to the manual toothbrushes (Niemi 1987; Boyd et al 1989; Walsh et al 1989). 
Others however have concluded that electric toothbrushes are more effective at plaque 
removal than manual toothbrushes (Stoltze & Bay 1994; Ainamo 1997) and that they 
are less abrasive to the gingivae (Niemi 1987). Some researchers have concluded that 
manual toothbrushes are better and have later changed their views following further 
research. A Cochrane review by Yaacob et al (2014) concluded that electric 
toothbrushes reduce plaque more than manual toothbrushes in the short and long term. 
Though this level of reduction will need further research to assess its clinical relevance. 
Therefore electric toothbrushes may be an oral hygiene adjunct for plaque control. 
 
2.12.3 Dental floss and interdental cleaning 
 
 Brushing in addition to the use of dental floss is a recommendation presented to 
patients by dentists on a regular basis. This is due to theory that using a toothbrush 
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alone will only clean three out of the five sides of a tooth leaving the mesial and distal 
surfaces. For small spaces between teeth it is very difficult to ensure plaque removal. In 
a Cochrane review conducted in 2011 the effectiveness of flossing combined with 
toothbrushing was assessed in comparison with toothbrushing alone. The highest level 
of clinical evidence was assessed and twelve randomised control trials were assessed 
which met the search criteria. The authors concluded that there is some evidence to 
show that flossing may reduce gingivitis compared with toothbrushing alone, though no 
strong evidence to show the effectiveness of flossing on the reduction of dental caries 
(Sambinjak et al. 2011).  
 
The development of interdental brushes has helped many patients in improving their 
oral hygiene and removal of plaque in large interdental spaces. This becomes a factor in 
areas of space closure during orthodontic treatment. Though there is limited high quality 
evidence to show the effectiveness of interdental brushes and their use in comparison 
to toothbrushing alone. There is weak evidence in the literature reporting the reduction 
of gingivitis when using interdental brushes. The authors of a systematic review which 
aimed to assess the effectiveness of interdental brushes concluded that the evidence 
was insufficient. The evidence was not sufficient enough to determine whether 
interdental brushes were better in plaque control when compared with floss (Poklepovic 
et al 2013).  
 
When looking at patient prefrences, there was clear evidence to suggest that patients 
had more problems when using dental floss when compared with the use of interdental 
brushes. Patients generally preferred the use of interndental brushes and according to 
an RCT had more of an effect on plaque levels. The theory is that patients would most 
likely use an interdental cleaning method that they prefer. The consistency of use would 
eventually result in consistent plaque reduction and the improvement of periodontal 
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health (Christou et al. 1998). Though as mentioned in the systematic review the 
evidence is not sufficient to conclude that interdental brushes are more effective 
(Poklepovic et al 2013). 
 
Other studies focussed on the psychological aspect of oral hygiene and interdental 
cleaning. Whether one decides to use floss or interdental brushes the most effective 
method to ensure patient compliance and use was using a combination of behavioural, 
cognitive and clinical management. This combination would aim in ensuring an 
adequate method, timing and duration of use. It would also improve patient’s confidence 
and planning which results collectively in the reduction of plaque and therefore 
periodontal disease (Clarkson et al. 2009).  
2.12.4 Mouthwash 
 
The remineralisation potential of fluoride use has been investigated in depth, and the 
guidelines have recommended its use in a number of different methods. One of which is 
in the form of fluoride mouthwash. A Cochrane review was conducted with the aim to 
investigate the effect of fluoride mouthwash with the two main available concentrations 
of 230 ppm daily or 900 ppm once every two weeks. After assessing a total of 48 trials 
that met the criteria, the combined results reported a reduction in decayed, missing and 
filled tooth surfaces (DMFT) by 23%. The systematic review concluded that fluoride 
mouthwash can reduce tooth decay in both children’s and adolescent’s permanent 
teeth. The studies assessed in this systematic review were at a school setting, and 
therefore the use of mouthwash was supervised. This directly effects the generalisability 
of the results and conclusions. The author however has concluded that the effects may 
be generalised in a supervised or non-supervised setting (Marinho et al. 2016).   
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Chlorohexidine (CHX) mouthwashes have also been suggested to reduce periodontal 
inflammation. In a recently updated systematic review the use of CHX mouthwash has 
suggested an improvement using the Loe and Silness gingival index (see periodontal 
indices section 2.11.1) though its clinical relevance is questionable. The use of CHX 
mouthwash in conjunction with routine OH measures has shown a reduction in levels of 
plaque, though the clinical relevance in the level of plaque reduction is questionable. 
CHX mouthwash has also been suggested as having a number of negative side effects 
when used for four weeks, which includes staining and calculus build-up. Therefore 
there is a questionable benefit to the routine use of CHX mouthwash and its 
recommendation according to this systematic review (James et al. 2017).  
2.12.5 Disclosing tablets 
 
 
The main definition of a disclosing agent and its use was described by Raybin as an 
agent which when applied on the tooth, makes visible the foreign matter (Raybin, 1943). 
The first disclosing solution was introduced by Skinner in 1914 with the use of iodine 
solution. Patients were asked to use the solution at home and ensure removing plaque. 
Berkwin in 1920 further developed a dye with a combination of brilliant green and crystal 
violet. Easlick in 1953 used bismark brown and Raybin in 1943 decided on a non-iodine 
dye of gentian violet (Cohen et al 1972). The main aims of a disclosing dye is to 
accurately dye plaque and locate the areas of accumulation. This would not only be 
beneficial for clinical use but also for at home use. This can also be an indication of the 
current level of plaque control. The ideal properties would include staining plaque, 
adequate colour intensity (to differentiate plaque with surroundings) and adequate 
duration of this colour intensity, adequate taste, non-allergic, non-irritating to the 
mucosa and water soluble (Sharma 2010).  Plaque has the ability to retain dye 
constituents due to the polarity difference, electrostatic interactions (with proteins) and 
hydrogen bonds (polysaccharides) made between the dye and plaque (Chetrus & Ion 
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2013). Whether solutions or tablets are used the dye should be absorbed by the pellicle 
layers (light colour and thin covering) and bacterial plaque layers (darker colour, thicker 
covering and more opaque). The disclosing material should not stain tooth or enamel.  
 
Disclosing agents have been used on clinics in an aim to locate areas which the patient 
is finding difficult to clean. This has been shown to be a very valuable adjunct to the 
basic verbal or written oral hygiene instructions given. In a survey conducted in 1993 
through the British Association for Orthodontists and the British Society for the Study of 
Orthodontics, 84% of orthodontists reported advising the use of disclosing tablets 
(Hobson & Clark 1998). In a single blinded randomised control trial participants were 
divided into four groups, where one group was shown images of plaque accumulation 
and its negative effects including demineralisation and gingival inflammation.  The other 
participants were either in a disclosing tablets alone group, disclosing tablets and 
images group or a control group. The authors concluded that when images were 
provided there was a significant difference in plaque index and gingival scores. Though 
no significant difference was observed when disclosing tablets were used alone in 
relation to the control group (Peng et al 2014). 
 
Therefore, numerous oral hygiene adjuncts are available. These have all been studied 
in depth to assess their effectiveness. Though systematic reviews continue to conclude 
that the clinical relevance is questionable with most adjuncts, the results may aid 
clinicians in advising patients on which adjunct may be effective. The recommendations 
must be individually catered to the patient to ensure their use in an aim for adequate 
plaque control.   
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3.0 Aims and Objectives 
 
3.1 Aims 
 
The principal research aim is to test the efficacy of the QScan oral hygiene device as an 
adjunct to at-home oral hygiene measures in Orthodontic patients (11 years of age or 
older) wearing upper and lower fixed Orthodontic appliances. 
3.2 Objectives 
3.2.1 Primary objective 
 
1. To assess if the oral hygiene regime using QScan results in a change related to 
plaque accumulation when compared to a control group who receive oral hygiene 
instructions and a fixed appliance starter pack only. 
3.2.2 Secondary objectives 
 
2. To assess if the oral hygiene regime using the QScan affects the occurrence of new 
demineralisation when compared to a control group who receive oral hygiene 
instructions and a fixed appliance starter pack only. 
 
3. To evaluate intra and inter-examiner reliability of the QLFD assessment.
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4.0 Trial design and methodology 
 
4.1 Design 
 
This study was conducted as a randomised controlled clinical trial. This design type was 
selected as it will help to produce data of high quality (Rosner 2012). 
4.2 Sample 
 
Consecutive patients attending Liverpool University Dental Hospital Orthodontic Department 
for fixed appliance Orthodontic treatment were considered for participation in the research. 
There was a systematic approach to patient selection. A random method of patient selection 
would have been preferable; however, this would have complicated the recruitment process 
and make it more difficult to gain the adequate number of participants within the available 
timeframe. 
4.3 Inclusion criteria 
 
 Subjects in good health with no medications. 
 Aged 11 years or older. 
 Planned for maxillary (upper) and mandibular (lower) fixed orthodontic 
appliances. 
 Adequate oral hygiene and dental health to commence Orthodontic treatment. 
4.4 Exclusion criteria 
 
 Patients that has significant disabilities which may influence manual dexterity.  
 These conditions would have influenced the patients’ ability to carry out oral 
hygiene measures and thus could have impacted plaque scores 
 Patients who had taken antibiotics within the two months immediately preceding 
the beginning of the study were excluded as this could alter the normal oral flora. 
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Patients who were given antibiotics during the study weren’t excluded but the 
details of the medication  was   recorded  in  relation  to:  antibiotic  type;  dose;  
indication  for administration and duration of treatment. 
 Subjects with restorations affecting more than one tooth surface due to the 
potential surface roughness influencing plaque retention (Bollenl et al. 1997). 
 Patients with active caries or periodontal disease as they would not have been 
considered appropriate for fixed Orthodontic treatment.  
4.5 Setting 
 
 
The trial was completed in the Orthodontic department at the Liverpool University Dental 
Hospital. Data was collected by the treating clinician at: 
 
 
i) T0- Baseline QLF-D photographs with patients undergoing fixed orthodontic 
treatment; 
ii) T1- At the first routine Orthodontic fixed-adjust appointment, approximately 6-8 
weeks from the baseline QLF-D photographs at T0; 
iii) T2- At the second Orthodontic fixed-adjust appointment, approximately 12-16 
weeks from the baseline QLF-D photographs at T0. 
 
Information obtained was analysed at the Liverpool University Dental Hospital research 
wing. All images were taken using white light followed by an automatic QLF-D 
photograph generated by the QLF-D camera (Canon EOS 550D Digital SLR Camera – 
equipped with lens containing 8 blue and 4 white LEDs). This was done after the teeth 
were dried with the use of an air-syringe for 5 seconds. The following settings were 
used: shutter speed of 1/20s, aperture value of 13.0 and ISO speed of 1600. The 
distance from the lens to the teeth was approximately 10cm.  
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4.6 Sponsorship, insurance and funding 
 
The protocol was peer reviewed and edited following the feedback provided. 
Sponsorship and insurance cover was approved by the University of Liverpool (see 
Appendices 14 and 15). Doctorate of Dental Science (DDSc) Liverpool University 
funding was used for this trial. 
4.7 Recruitment and anonymisation of data 
 
 
Consecutive patients attending for their routine fix/adjustment Orthodontic appointments 
were included. Written information was given to patients in relation to participating in the 
study, and for those under 16 years of age a parent or guardian was given written 
information. This was explained in the participation information sheets for children 11-
13, 14-15, over 16 and parents/guardians (Appendices 4, 5, 6 and 7). This information 
was given before the initial baseline session. The main aims and basic information 
about the study was explained verbally (in addition to in writing) by the clinician to the 
patient and their parent/guardian where relevant. This included approximately a 15 
minute verbal explanation, and 15 minutes in private to read the information leaflet. An 
opportunity was given to ask questions at any stage. If they wanted to proceed with 
participation in the research, consent was obtained by the lead clinician or chief 
investigator on the same day from either the patient or parent/guardian. Anyone who 
was unsure was given until their next appointment to decide whether they wanted to 
partake in the study. 
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4.8 Randomisation 
 
After participants agreed to partake and consent was obtained, a base line QLF-D 
assessment was completed (T0). This was done at the baseline appointment and 
involved photographs being taken using the QLF‐D device for both the maxillary and 
mandibular dentition. This was initially done to assess for plaque deposits (Figure 
15). The incisors were in an edge-to-edge relationship for frontal and buccal views, 
and out of occlusion for the lingual and palatal views. Plaque deposits noted were 
removed and another photograph was taken to allow for the assessment of 
demineralisation (Figure 16). 
Figure 15 - QLF-D photo 
showing plaque deposits in 
florescent pink before 
removal for demineralisation 
assessment 
Figure 16 - QLF photo 
following plaque removal to 
assess for demineralisation 
that may be found below the 
plaque deposits evident in 
the previous photo (figure 
14) 
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QLF-D images were formally assessed for plaque presence and demineralisation 
and classed as low or high risk of demineralisation by QLF Researcher (SS). If a 
single area of demineralisation was evident the patient was considered as being at 
high risk for demineralisation. 
 
Patients were randomly divided into two groups by an independent statistician (GB). 
This was done by the generation of a random number sequence by a computer 
generated programme. The randomisation process was stratified by demineralisation 
risk into high and low risk groups following assessment of the baseline QLF-D data. 
Allocation concealment was completed using consecutively numbered, sealed 
opaque envelopes. At the baseline appointment the envelope was opened based on 
the demineralisation risk, and the patient was allocated to one of the two parallel 
groups. Blinding of the participant or operator to the group allocation was not 
possible. All participants were treated by the same lead operator (DDSc student – 
SS – supervised by Orthodontic consultants at Liverpool University Dental Hospital). 
 
Group 1 (intervention group) received the fixed appliance starter pack as per normal 
hospital procedure (see Appendix 1 for list of components) as well as a QScan 
device (see Appendix 2 - Inspektor Technology, The Netherlands) to take home with 
them. The QScan written instructions were provided and are included in the 
appendix section of this thesis (Appendix 3). Those who receive the QScan device 
were also given verbal instructions on how and when to use the device when at 
home. Group 2 (control) received the fixed appliance starter pack only. All patients 
received verbal and written oral hygiene instructions advising brushing twice a day: 
first thing in the morning and before bed. They were also advised to use a fluoridated 
mouthwash once a day at a different time to brushing. It was not possible to blind the 
clinician or patient, but the data (QLF-D photographs) was randomly coded when 
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saved. The random coding was revealed at a later stage by an independent 
investigator for data analysis. This was done so that there was no indication to the 
investigator on which group the patient was allocated to. 
4.9 Data collection 
 
The baseline data (QLF-D photographs) were collected on the day the patient 
formally agreed to participate in the study (T0), which allowed for stratification of the 
participants according to the risk of demineralisation as outlined above. The patients 
were assigned to their groups after the baseline photos. Oral hygiene was assessed 
as per normal procedure at every appointment. QLF-D images were taken at the first 
fixed adjust appointment following baseline (6-8 weeks) and then following another 
fixed adjust appointment (12-16 weeks from baseline). 
 
 
 
 
 
 
 
 
Figure 17 - White light photo 
using QLF-D 
Figure 18 - QLF photo using 
QLF-D 
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As the QLF-D takes both QLF and white light photos at the same time (see Figures 
17 and 18), white light photos were also available to use as a clinical reference to 
accompany the QLF data. At each visit the archwires were kept in place and the 
QLF-D device was used to take photographs of maxillary and mandibular teeth. The 
patient’s teeth were in an edge-to-edge position for the frontal/buccal views (where 
appropriate) and not in occlusion for the palatal and lingual (Figure 19). The patients 
in the intervention group were required to bring their Q‐Scan device to each 
appointment so that the operator could make sure it was functioning correctly. At 
each appointment participants in both groups were given feedback from the operator 
in relation to their oral hygiene/plaque control, using the QLF-D images as a visual 
aid. These images were at the same magnification, focus and direction as the 
baseline photos. The oral hygiene instructions given were standardised to be the 
same as that which was explained at the initial appointment, but will also highlight 
any specific areas demonstrating plaque stagnation. As per normal procedure within 
the Orthodontic Department if a participants’ oral hygiene was consecutively of a 
poor standard deeming the patient at high risk of progressing demineralisation, the 
appliances were removed. 
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Figure 19 - Complete set of photos taken for plaque assessment which included a 
frontal, right buccal, left buccal, palatal and lingual photograph using white light (A) 
followed by automatic QLF photographs (B). 
A 
B 
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4.10 Image analysis 
 
Images were stored using the patients’ allocated random number on an electronic 
database. An independent investigator randomised the coding and images to allow 
for analysis to be free of any recall bias. 
 
Plaque accumulation was measured on each tooth and represented as a percentage 
of tooth coverage demonstrating red fluorescence. For analysis purposes, this was 
graded at ∆R30. The teeth to be assessed were outlined using a cursor to limit the 
teeth to be assessed at each photo (Figure 20). A decision was made to divide the 
teeth to be assessed as follows to ensure no duplication of the measurements: 
 
1) Frontal photo (F) – Assessing the upper and lower incisors including the 
canines  
2) Buccal photos (A/B) – Assessing the first premolar, second premolar and first 
molar on the left hand side with the photo assessing the left buccal surfaces 
and on the right hand side with the photo assessing the opposite buccal 
surfaces 
3) Palatal and lingual photos (P/L) – Assessing all the occlusal, palatal and 
lingual surfaces on all of the teeth up to and including the first molars 
 
Demineralisation was calculated by initially drawing an outline around each lesion 
with borders resting on sound enamel (Figure 21). If the adjacent structure was not 
sound enamel, such as a bracket edge, the outline was adjusted to account for this. 
The mean fluorescence loss (∆F) and maximum fluorescence loss was assessed 
and compared to the fluorescence of the surrounding sound enamel. This was 
assessed per pixel, comparing the lesion area involved and the surrounding sound 
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enamel. If there was more than one demineralised lesion on a tooth the total 
fluorescence loss was calculated as two separate areas on the tooth. 
 
 
 
 Figure 20 - Image analysis for plaque involves outlining the teeth to be 
assessed and the system detects areas of plaque accumulation evident. 
Figure 21 - Areas of demineralisation is outlined and assessed in relation to the 
change in florescence between the demineralised tissue and surrounding sound 
enamel 
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5.0 Statistical analysis 
 
5.1 Reliability, sensitivity and specificity assessments 
 
To determine if the examiners had the ability to correctly identify the presence or 
absence of demineralisation, 10 QLF-D images were assessed by 2 examiners. 
These selected images were displayed at random and assessed independently to 
avoid any recall bias influencing outcomes. The results were compared to the main 
assessor’s analysis (GK), which was assumed to be the gold standard. This was to 
assess for inter-examiner reliability. This examiner had previous experience using 
the software and analysing the experimental data type. To assess intra-examiner 
reliability, the main investigator (SS) repeated analysis of 10 randomly selected QLF-
D images 2 weeks apart. Intra and inter-examiner reliability was conducted using the 
Stats Direct (version 3.0) program using the inter class correlation coefficient (ICC). 
This was completed under the supervision of an experienced statistician (GB). 
5.2 Sample size calculation 
 
To our knowledge there has been no previous randomised controlled trials on the 
use of Q-Scan oral hygiene device at the start of the experiment to allow for a 
sample size calculation. A sample size of 60 was deemed appropriate, allowing for 
30 participants in each group (intervention and control). The information gained, was 
used to assist in the estimation of parameters for a sample size calculation to be 
conducted. This in turn, could be used for future definitive studies. 
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5.3 Normality testing and hypothesis testing 
 
The primary outcome variable was the change in plaque accumulation at tooth level 
measured on 3 occasions: from the baseline appointment (T0) and during the continuing 
treatment of patients with upper and lower fixed appliances. This meant assessing the 
participants at the following 2 adjustment appointments (T1-T2) using the QLF-D 
photographs. Plaque accumulation was represented as a percentage of tooth 
coverage demonstrating red fluorescence at ∆R30. 
 
The secondary outcome was the development of demineralisation at tooth level also 
measured on the same 3 occasions, as in the primary outcome assessment: from 
the baseline appointment (T0) and during the continuing treatment of patients with 
upper and lower fixed appliances. This meant assessing the participants at the 
following 2 adjustment appointments (T1-T2) using the QLF-D photographs. This 
was measured as ∆F using the QLF-D photographs. A statistical comparison was 
carried out between the two groups to give estimates of the effect of size and 
variability, which could be used to assist in the design of future research.  
5.4 Receiver operating characteristic (ROC) curves 
 
These were used to assess the loss of fluorescence on QLF-D images and to 
evaluate the performance of QLF as a diagnostic method. These ROC curves give 
an indication of the overall value of this test for demineralisation quantification and 
their use is reported to be appropriate when a test is based on an ‘observed variable 
that lies on a continuous or graded scale’ (DeLong et al. 1988). 
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5.5 Reliability data 
 
Using the QLF-D images, data on plaque accumulation and demineralisation was 
continuous and both intra and inter-examiner reliability was evaluated using intra-
class correlation coefficient (ICC). 
5.5 Sensitivity and specificity of data 
 
Sensitivity was calculated by assessing the level of demineralisation in relation to the 
gold standard, which was the main assessors’ analysis of the QLF-D images. This 
will act to provide a measure of QLFs’ diagnostic accuracy of demineralisation.
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6.0 Results 
 
6.1 Recruited participants 
 
The participants were recruited according to the inclusion and exclusion criteria with 
originally 60 patients agreeing to take part in the study. Four participants were 
removed from the study due to poor attendance missing multiple back to back 
appointments. The missed appointments affected their orthodontic treatment and 
data collection for this study. These participants were contacted on the phone and a 
letter was later sent to them and their general dental practitioner, asking to contact 
the department to arrange for an appointment. Contacting the patients with a letter 
following multiple appointments missed is an NHS trust policy, and the four 
participants did not respond to the letters and did not contact the department. 
Therefore, a total of 56 participants completed the trial. The participant’s details are 
outlined in table 10. The QScan group had a near equal number of male to female 
participants (15M/13F) whilst the control group had more females than males 
(6M/22F). The average age for the patients was around 16 years for both groups. 
 
Participant Details 
 QScan Control 
Number of participants 28 28 
Gender (M/F) 15M/13F (46% Female) 6M/22F (79% Female) 
Age (mean) 16.014 (SD = 5.87) 16.085 (SD = 5.29) 
 
Table 10 - Participant details in relation to the number of participants in each 
group, gender and the mean age range 
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6.2 Appointment duration 
 
Data was collected at three consecutive orthodontic appointments at the dental 
hospital. Patients undergoing orthodontic treatment had appointments arranged 
every 6-8 weeks in an aim to readjust their fixed orthodontic appliances. The two 
groups on average had the same time period between appointments. There was a 
difference of 3.5 days between the two groups from T0-T1 with the QScan group 
being seen on an average 51 day period and the control group at 54 days. At T1-T2 
the total difference was 2.1 days. The QScan group were seen on an average 59 
day period and the control group at 57 days, following their previous appointment. 
Therefore the total difference from T0-T2 between the two groups was less than a 
day. The mean duration between appointments is outlined in the table below (Table 
11): 
 
Duration between appointments 
Group T0-T1 T1-T2 T0-T3 
QScan - Mean (SD) 51.5 (16.9) 59.4 (15.1) 110.9 (28.0) 
Control - Mean (SD) 54.0 (22.9) 57.3 (13.9) 111.3 (26.4) 
 
Table 11 – Appointment duration between appointments in both the QScan and 
Control groups from T0-T3 
 
6.3 Intra and inter reliability assessment: 
 
Prior to data analysis, reliability assessment was completed. Intra reliability was 
completed with researcher SS in an aim to assess reliability in quantifying plaque 
accumulation ΔR. This was completed following a two week washout period 
assessing a total of 10 records. The intra reliability score using the inter class 
correlation coefficient (ICC) was 0.997. This is considered excellent according to the 
interpretation by Ko and Lee (2016). Inter reliability was also assessed starting with 
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plaque accumulation in coordination with researcher GK. As in the intra-reliability a 
total of 10 records were assessed. This was also in an aim to assess the reliability 
associated with quantifying plaque accumulation ΔR. A comparison was made in 
relation to the results of the primary researcher SS. The inter reliability was 
completed using ICC with a score of 0.997 (excellent). The intra and inter reliability 
assessments were repeated for quantifying demineralisation ΔF. The intra reliability 
resulted in a score of 0.997 (excellent) and the inter reliability with a score of 0.937 
(excellent) also assessing 10 records. Therefore the intra and inter reliability 
assessment resulted in high scores with an interpretation of excellent reliability for 
quantifying plaque ΔR and demineralisation ΔF. The detailed intra and inter reliability 
scores are outlined in table 12.  
 
Intra and inter reliability for plaque accumulation and demineralisation (ICC) 
Assessment Plaque accumulation Demineralisation 
Intra reliability  0.998  0.997 
Inter reliability  0.997   0.937 
 
Table 12 - Intra and inter reliability scores for plaque accumulation and 
demineralisation 
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6.4 Flowchart of the clinical phase 
 
In total 61 patients were approached to take part in the study. Only one of which 
declined to take part due to the understanding that the QLF photos taken would add 
time to their orthodontic appointment. Therefore 60 patients were randomised to the 
two groups (QScan and control). Two patients in each group were lost to follow up 
due to poor attendance to the orthodontic appointments. The four patients did not 
attend any appointments throughout the period of the trail following their initial 
appointment. The data for the 56 patients remaining were all analysed (Figure 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 - The Consort participant flow diagram for patients’ 
recruitment, allocation and analysis 
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6.5 Plaque accumulation 
 
Following inter and intra reliability the data was analysed in an aim to assess the 
primary outcome which was the changes in plaque accumulation for patients in both 
the QScan group and the control group. This was done in relation to the changes of 
plaque accumulation between T0-T1, T1-T2 and T0-T2 within each group using a t-
test. Following the assessment of changes within each group a t-test was completed 
in an aim to assess the significance of the changes between both groups. This test 
was chosen due to the normal distribution of the continuous data in ΔR. The 
assessment was made in relation to surfaces; frontal (F), right buccal (A), left buccal 
(B), palatal (P) and lingual (L). The assessments aimed to assess changes not only 
as a whole but also in sections between the QScan group and control group at 
changes in time points T1, T2 and T3. These sections were divided as follows: 
1) FABPL (Frontal, right Buccal, left Buccal, Palatal and Lingual sections) 
2) FAB (Frontal, right Buccal and left Buccal sections) 
3) PL (Palatal and Lingual sections) 
4) F (Frontal section) 
5) A (Right Buccal section) 
6) B (Left Buccal section) 
7) P (Palatal section) 
8) L (Lingual section) 
This was done in an aim to assess the effect and changes observed not only as a 
whole (FABPL) in relation to the total change in plaque accumulation but also in 
relation to smaller sections (FAB and PL) and individual ones (F, A, B, P and L). The 
statistical analysis was completed using SPSS (version 24.0, IBM Corporation, 
Armonk, NY, USA) under the supervision of an experienced statistician (GB). The 
results for the sections above were as follows: 
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1) FABPL - Frontal, Right Buccal, Left Buccal, Palatal and Lingual 
sections 
The plaque accumulation and assessment was as mentioned above assessed in 
relation to the time points T0-T1, T1-T2 and T0-T2 between the two groups. The 
average changes looking at all the surfaces (Figure 23) from T0-T1 in the QScan 
was greater    (3.6) than the control group (-1.53). The changes showed a reduction 
in plaque accumulation in the QScan group when compared with the control group 
which had an increase in the amount of plaque from T0-T1. These changes when 
assessed revealed a significant difference following a t-test analysis (p<0.001 – 95% 
CI for difference 3.27-6.51). The same pattern was apparent when assessing the 
changes at T1-T2 in which the QScan group plaque scores reduced (0.59) whilst the 
control group plaque levels increased (-0.49) which also revealed a significant 
difference (p<0.05 – 95% CI for difference 0.51-2.41). With both groups showing 
significant changes when compared at points T0-T1 and T1-T2, the overall changes 
between T0-T2 revealed a substantial reduction in plaque accumulation in the 
QScan group (4.19) and an increase in plaque accumulation in the control group (-
2.02) which was also statistically significant revealing a p<0.001 on a 95% CI for 
difference 4.78-7.65 (Table 13, Figure 24). 
Figure 23 - FABPL (Frontal, right Buccal. left Buccal, 
Palatal and Lingual) 
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Plaque accumulation (ΔR) all surfaces (FABPL) 
Group Mean (SD) Mean (SD) Difference (SD) Mean Difference (95% CI) P - value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 10.11 (7.91) 6.51 (4.61) 3.28 (4.85) 4.89 (3.27-6.51) <0.001  
Control 7.76 (6.25) 9.29 (8.30) -1.61 (6.51)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  6.51 (4.61) 5.92 (3.76) 0.52 (1.09) 0.92 (0.51-2.41) 0.030  
Control 9.29 (8.30) 9.78 (8.52) -0.39 (1.62)  
Plaque T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 10.11 (7.91) 5.92 (3.76) 4.19 (6.03) 6.21 (4.78-7.65) <0.001  
Control 7.76 (6.25) 9.78 (8.52) -2.02 (6.19)  
 
Table 13 - Plaque accumulation (ΔR) all surfaces (FABPL) means, standard 
deviations and effects. 
 
 
T0 T1 T2
Qscan 10.11 6.51 5.92
Control 7.76 9.29 9.78
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Figure 24 – Chart of the Plaque accumulation levels (ΔR) of all surfaces 
(FABPL). 
 
 
 
 
 
 
 
 
 
80 
 
2) FAB - Frontal, Right Buccal and Left Buccal sections 
 
The average changes looking at the frontal and buccal surfaces (Figure 25) from T0-
T1 in the QScan was greater (5.01) than the control group (-1.56). The changes also 
showed a reduction in plaque accumulation in the QScan group when compared with 
the control group which had a slight increase in plaque accumulation. These 
changes when assessed revealed a significant difference following a t-test analysis 
(p<0.001 – 95% CI for difference = 2.93 – 10.78). The same pattern was apparent 
when assessing the changes at T1-T2 in which the QScan group scores reduced 
(1.09) whilst the control group increased (-0.88) which also revealed a significant 
difference (p<0.05 – 95% CI for difference = 0.35 – 3.29). With both groups showing 
significant changes when compared at points T0-T1 and T1-T2, the overall changes 
between T0-T2 revealed a substantial reduction in plaque accumulation in the 
QScan group (6.1) and an increase in plaque accumulation in the control group (-
2.44) which was also statistically significant revealing a p<0.001 on a 95% 
confidence interval which was between 5.00 – 12.07 (Table 14, Figure 26).  
 
 
 
 
 
 
 
 
 
 
Figure 25 - FAB (Frontal, right Buccal and left Buccal) 
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 Plaque accumulation (ΔR) for the frontal and buccal surfaces (F/A/B)  
Group Mean (SD) Mean (SD) Difference (SD) Mean Difference (95% CI) P- value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 13.25 (8.04) 8.24 (4.29) 5.01 (4.26)  8.54 (2.93 – 10.78) 0.001 
Control 9.30 (6.16) 10.86 (8.74) -1.56 (7.30)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  8.24 (4.29) 7.15 (3.58) 1.09 (2.94)  1.46 (0.35 – 3.29) 0.016 
Control 10.86 (8.74) 11.74 (9.008) -0.88 (3.76)  
Plaque T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 13.25 (8.04) 7.15 (3.58) 6.10 (5.77)  6.86 (5.00 – 12.07) <0.001 
Control 9.30 (6.16) 11.74 (9.008) -2.44 (7.33)  
 
Table 14 - Plaque accumulation (ΔR) for the frontal and buccal surfaces (F/A/B) 
means, standard deviations and effects. 
 
 
T0 T1 T2
QScan 13.25 8.24 7.15
Control 9.3 10.86 11.74
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Figure 26 – Chart of the Plaque accumulation (ΔR) for the frontal and buccal 
surfaces (F/A/B). 
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3) PL - Palatal and Lingual sections 
 
Finally the last joint surface assessment was looking at the palatal and the lingual 
surfaces (Figure 27). The average changes looking at all the surfaces from T0-T1 in 
the QScan was near the same (1.49) as in the control group (-1.48). The QScan 
group had a reduction in plaque accumulation and the control group had an increase 
in plaque by around the same amount. These changes when assessed revealed a 
significant difference following a t-test analysis (p<0.001 – 95% CI for difference = 
0.36 – 3.51). This pattern was reversed when assessing the changes at T1-T2 in 
which the QScan group scores increased (-0.15) and the control group decreased 
(0.09) which also revealed a significant difference (p<0.05 – 95% CI for difference = 
0.02 – 1.82). With both groups showing significant changes when compared at 
points T0-T1 and T1-T2, the overall changes between T0-T2 revealed a reduction in 
plaque accumulation in the QScan group (1.34) and an increase in plaque 
accumulation in the control group (-1.39) which was also statistically significant 
revealing a p<0.001 on a 95% confidence interval for difference between 3.87 – 9.01 
(Table 15, Figure 28). 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 - PL (Palatal and Lingual) 
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Plaque accumulation (ΔR) for the frontal and buccal surfaces (P/L) 
Group Mean (SD) Mean (SD) Difference (SD) Mean Difference (CI 95%) P-Value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 5.41 (4.78) 3.92 (3.83) 0.69 (1.66) 1.93 (0.36 – 3.51) 0.017 
Control 5.45 (5.70) 6.93 (7.04) -1.24 (2.95)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  3.92 (3.83) 4.07 (3.27) 0.53 (1.09) 0.92 (0.02 – 1.82) 0.045 
Control 6.93 (7.04) 6.84 (6.81) -0.39 (1.62)  
Plaque T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 5.41 (4.78) 4.07 (3.27) 1.34 (2.13) 2.73 (3.87 – 9.01) <0.001 
Control 5.45 (5.70) 6.84 (6.81) -1.39 (2.29)  
 
Table 15 – Plaque accumulation (ΔR) for the palatal and lingual surfaces (P/L) 
means, standard deviations and effects. 
 
 
 
T0 T1 T2
QScan 5.41 3.92 4.07
Control 5.45 6.93 6.84
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Figure 28 - Chart of the Plaque accumulation (ΔR) for the palatal and lingual 
surfaces (P/L). 
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4) F – Frontal section 
 
The average changes looking at the frontal surfaces (Figure 29) from T0-T1 in the 
QScan group was greater (3.94) than the control group (-1.65). The changes also 
showed a reduction in plaque accumulation in the QScan group when compared with 
the control group which showed an increase in plaque. These changes when 
assessed revealed a significant difference following a t-test analysis (p<0.05 – 95% 
CI for difference = 1.82 – 9.37). This same pattern was apparent when assessing the 
changes at T1-T2 in which the QScan group scores reduced (1.44) whilst the control 
group increased (-0.96) which also revealed a non-significant difference (p>0.05 – 
95% CI for difference = -0.36 – 5.16). The overall changes between T0-T2 revealed 
a substantial reduction in plaque accumulation in the QScan group (5.46) and an 
increase in plaque accumulation in the control group (-2.43) which was also 
statistically significant revealing a p<0.001 on a 95% confidence interval for 
difference between 4.31 – 11.47 (Table 16, Figure 30). 
 
Figure 29 - F (Frontal) 
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Table 16 - Plaque accumulation (ΔR) for the frontal surfaces (F) means, 
standard deviations and effects. 
 
 
T0 T1 T2
QScan 11.11 6.94 5.64
Control 7.86 9.61 10.29
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Figure 30 - Chart of the Plaque accumulation (ΔR) for the frontal surfaces (F). 
 
 
 
 
Plaque accumulation (ΔR) for the frontal surface (F) 
Group Mean (SD) Mean (SD) Difference (SD) Mean Difference (CI 95%) P- Value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 11.11 (6.97) 6.94 (3.70) 3.94 (4.67)  5.60 (1.82 – 9.37) 0.005 
Control 7.86 (5.77) 9.61 (7.43) -1.65 (6.75)  
Plaque T2-T3 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  6.94 (3.70) 5.64 (3.22) 1.44 (2.18) 2.40 (-0.36 – 5.16) 0.086 
Control 9.61 (7.43) 10.29 (8.70) -0.96 (5.44  
Plaque T1-T3 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 11.11 (6.97) 5.64 (3.22) 5.46 (6.35)  7.90 (4.31 – 11.47) <0.001 
Control 7.86 (5.77) 10.29 (8.70) -2.43 (7.01)  
F Pl que Accumulation Means 
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5) A – Right Buccal section 
 
The average changes looking at the right buccal surfaces (Figure 31) from T0-T1 in 
the QScan group was greater (6.67) than the control group (-1.35). The changes 
displayed a reduction in plaque accumulation in the QScan group when compared 
with the control group which showed an increase in plaque. These changes when 
assessed revealed a significant difference following a t-test analysis (p<0.05 – 95% 
CI for difference = 2.75 – 13.28). This same pattern was apparent when assessing 
the changes at T1-T2 in which the QScan group scores reduced (1.89) whilst the 
control group increased (-1.09) which also revealed a significant difference (p<0.05 – 
95% CI for difference = 0.30 – 5.66). The overall changes between T0-T2 revealed a 
substantial reduction in plaque accumulation in the QScan group (7.68) and an 
increase in plaque accumulation in the control group (-2.21) which was also 
statistically significant revealing a p<0.001 on a 95% confidence interval for 
difference between 5.50 – 14.30 (Table 17, Figure 32). 
 
 
 
 
 
Figure 31 - A (right Buccal) 
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Table 17 - Plaque accumulation (ΔR) for the right buccal surfaces (A) means, 
standard deviations and effects. 
 
 
T0 T1 T2
QScan 15.32 9.44 7.64
Control 10.75 11.7 12.96
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Figure 32 - Chart of the Plaque accumulation (ΔR) for the right buccal surfaces 
(A). 
 
  
 
Plaque accumulation (ΔR) for the buccal surface on the right hand side (A) 
Group Mean (SD) Mean (SD) Difference (SD) Difference Mean (CI 95%) P- value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 15.32 (8.17) 9.44 (4.72) 6.67 (5.89)  8.01 (2.75 – 13.28) 0.004 
Control 10.75 (6.26) 11.70 (9.69) -1.35 (9.73)  
Plaque T2-T3 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  9.44 (4.72) 7.64 (3.32) 1.89 (4.20)  2.98 (0.30 – 5.66) 0.030 
Control 11.70 (9.69) 12.96 (9.40) -1.09 (4.22)  
Plaque T1-T3 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 15.32 (8.17) 7.64 (3.32) 7.68 (7.07)  9.89 (5.50 – 14.30) <0.001 
Control 10.75 (6.26) 12.96 (9.40) -2.21 (9.21)  
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6) B – Left Buccal section 
 
The average changes looking at the left buccal surfaces (Figure 33) from T0-T1 in 
the QScan group was greater (4.39) than the control group (-2.57). The changes 
displayed a reduction in plaque accumulation in the QScan group when compared 
with the control group which showed an increase in plaque. These changes when 
assessed revealed a significant difference following a t-test analysis (p<0.05 – 95% 
CI for difference = 2.90 – 11.05). The same pattern was apparent when assessing 
the changes at T1-T2 in which the QScan group scores reduced (0.22) whilst the 
control group increased (-0.30) which also revealed a non-significant difference 
(p>0.05 – 95% CI for difference = -2.32 – 2.48) due to a reduction and increase of no 
more than a single unit in both groups. The overall changes between T0-T2 revealed 
a substantial reduction in plaque accumulation in the QScan group (5.14) and an 
increase in plaque accumulation in the control group (-2.68) which was also 
statistically significant revealing a p<0.001 on a 95% confidence interval for 
difference between 4.30 – 11.35 (Table 18, Figure 34). 
 
 
 
 
Figure 33 - B (left Buccal) 
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Plaque accumulation (ΔR) for the buccal surfaces on the left hand side (B) 
Group Mean (SD) Mean (SD) Difference (SD) Difference Mean (CI 95%) P- value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 13.32 (8.62) 8.33 (4.26) 4.39 (5.30) 6.95 (2.90 – 11.05) 0.001 
Control 9.29 (6.30) 11.26 (9.20) -2.57 (7.19)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  8.33 (4.26) 8.18 (3.76) 0.22 (3.80) 0.082 (-2.32 – 2.48) 0.945 
Control 11.26 (9.20) 11.96 (9.03) -0.30  
Plqaue T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 13.32 (8.62) 8.18 (3.76) 5.14 (6.45) 7.82 (4.30 – 11.35) <0.001 
Control 9.29 (6.30) 11.96 (9.03) -2.68 (6.74)  
 
Table 18 - Plaque accumulation (ΔR) for the left buccal surfaces (B) means, 
standard deviations and effects. 
 
 
T0 T1 T2
QScan 13.32 8.33 8.18
Control 9.29 11.26 11.96
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Figure 34 - Chart of the Plaque accumulation (ΔR) for the left buccal surfaces 
(B). 
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7) P – Palatal section 
 
The changes looking at the palatal surfaces (Figure 35) from T0-T1 was a reduction 
in the QScan (0.92) and an increase in the control group (-0.99). The changes 
displayed a reduction in plaque accumulation in the QScan group when compared 
with the control group which showed an increase in plaque. These changes when 
assessed revealed a non-significant difference following a t-test analysis (p>0.05 – 
95% CI for difference = -0.50 – 2.22). The opposite pattern was apparent when 
assessing the changes at T1-T2 in which the QScan group scores increased (-0.71) 
whilst the control group reduced (0.42) which also revealed a non-significant 
difference (p>0.05 – 95% CI for difference = -0.78 – 0.88). The overall changes 
between T0-T2 revealed a slight reduction in plaque accumulation in the QScan 
group (0.21) and an increase in plaque accumulation in the control group (-0.57) 
which was also non-significant revealing a p>0.05 on a 95% confidence interval for 
difference between -0.41 – 1.71 (Table 19, Figure 36). 
 
 
 
 
 
Figure 35 - P (Palatal) 
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Plaque accumulation (ΔR) for the palatal surface (P) 
Group Mean (SD) Mean (SD) Difference (SD) Difference Mean (CI 95%) P- value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 3.64 (2.53) 2.72 (2.87) 0.92 (1.66) 0.857 (-0.50 – 2.22) 0.211 
Control 3.75 (5.32) 4.74 (5.60) -0.91 (2.45)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  2.72 (2.87) 3.43 (3.06) -0.71 (1.21) 0.048 (-0.78 – 0.88) 0.907 
Control 4.74 (5.60) 4.32 (5.60) 0.42 (1.37)  
Plqaue T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 3.64 (2.53) 3.43 (3.06) 0.21 (1.31) 0.79 (-0.14 – 1.71) 0.093 
Control 3.75 (5.32) 4.32 (5.60) -0.57 (2.04)  
 
Table 19 - Plaque accumulation (ΔR) for the palatal surfaces (P) means, 
standard deviations and effects. 
 
 
 
T0 T1 T2
QScan 3.64 2.72 3.43
Control 3.75 4.74 4.32
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Figure 36 - Chart of the Plaque accumulation (ΔR) for the palatal surfaces (P). 
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8) L – Lingual section 
 
The changes looking at the lingual surfaces (Figure 37) from T0-T1 was a reduction 
in the QScan (7.18 to 5.11) and an increase in the control group (7.14 to 9.13). The 
changes displayed a reduction in plaque accumulation in the QScan group when 
compared with the control group which showed an increase in plaque. These 
changes when assessed revealed a significant difference following a t-test analysis 
(p<0.05 – 95% CI for difference = 0.59 – 5.44). The same pattern was apparent 
when assessing the changes at T1-T2 in which the QScan group scores reduced 
(5.11 to 4.71) whilst the control group increased (9.13 to 9.36) which also revealed a 
significant difference (p<0.05 – 95% CI for difference = 0.17 – 3.41). The overall 
changes between T0-T2 revealed a substantial reduction in plaque accumulation in 
the QScan group (7.18 to 4.71) and an increase in plaque accumulation in the 
control group (7.14 to 9.36) which was also significant revealing a p<0.05 on a 95% 
confidence interval for difference between 2.61 – 6.7 (Table 20, Figure 38). 
 
 
 
 
 
Figure 37 - L (Lingual) 
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Plaque accumulation (ΔR) for the lingual surface (L) 
Group Mean (SD) Mean (SD) Difference (SD) Difference Mean (CI 95%) P- value 
Plaque T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan 7.18 (5.80) 5.11 (4.35) 2.07 (2.60) 3.01 (0.59 – 5.44) 0.016 
Control 7.14 (5.65) 9.13 (7.16) -1.99 (4.53)  
Plaque T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  5.11 (4.35) 4.71 (3.40) 0.4 (1.92) 1.79 (0.17 – 3.41) 0.031 
Control 9.13 (7.16) 9.36 (7.07) -0.23 (2.93)  
Plqaue T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan 7.18 (5.80) 4.71 (3.40) 2.47 (4.34) 4.68 (2.61 – 6.75) <0.001 
Control 7.14 (5.65) 9.36 (7.07) -2.22 (3.30)  
 
Table 20 - Plaque accumulation (ΔR) for the lingual (L) means, standard 
deviations and effects. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38 - Chart of the Plaque accumulation (ΔR) for the lingual surface (L). 
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6.6 Demineralisation 
 
Following the assessment of the primary outcome in relation to the plaque 
accumulation an assessment was completed to look at the changes in 
demineralisation. The changes in demineralisation were assessed in relation to all 
the surfaces combined for each patient. Not all the patients had areas of 
demineralisation though they were stratified originally in relation to high or low risk of 
demineralisation. As mentioned in the methods this was assessed in relation to the 
current demineralisation status of each patient and the number of demineralisation 
sites. The demineralisation score was (ΔF) which is the change in fluorescence 
between the area of demineralisation and sound tooth tissue. An area of 
demineralisation would have a reduction in fluorescence and therefore a negative 
score. The mean demineralisation score at T0 was -7.87 which increased even 
further at T1 and a ΔF score of -8.49 (increase in demineralisation). The 
demineralisation improved at T2 with an increase in the ΔF score and a reduction in 
demineralisation revealing a score of -8.26. The changes in demineralisation of the 
control group was an initial reduction of demineralisation of 0.62 from T0 to T1. 
There was then an increase in demineralisation from T1-T2 with ΔF score reduction 
and increase in demineralisation of -0.62. The overall change from T0-T2 was an 
improvement of demineralisation by 0.31. When assessing the changes in the 
means and the fluctuation apparent between the groups at the different time points, 
the t tests revealed the following: a non-significant difference between the two 
groups from T0-T1, T1-T2 and from T0-T2 with a p>0.05 (Table 21, Figure 39).  
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Demineralisation (ΔF) 
Group Mean (SD) Mean (SD) Difference (SD) Difference Mean (CI 95%)  
Demin T0-T1 T0 T1 T0-T1 T0-T1 T0-T1 
QScan -7.87 (2.52) -8.49 (2.59) -0.62 (1.09) 0.37 (-0.97 – 1.72) 0.576 
Control -11.43 (6.73) -10.81 (6.65) 0.62 (2.03)  
Demin T1-T2 T1 T2 T1-T2 T1-T2 T1-T2 
QScan  -8.49 (2.59) -8.26 (2.44) 0.23 (0.80) -0.72 (-1.61 – 1.47) 0.924 
Control -10.81 (6.65) -11.43 (6.03) -0.62 (2.42)  
Demin T0-T2 T0 T2 T0-T2 T0-T2 T0-T2 
QScan -7.87 (2.52) -8.26 (2.44) -0.39 (0.68) 0.17 (-9.71 – 1.748) 0.561 
Control -11.43 (6.73) -11.12 (6.03) 0.31 (2.24)  
 
Table 21 - Demineralisation (ΔF) for all the surfaces combined and a detailed 
description of the means, standard deviations and the effects. 
 
 
T0 T1 T2
QScan -7.87 -8.49 -8.26
Control -11.43 -10.81 -11.12
-15
-10
-5
0
Δ
F
Demineralisation
 
Figure 39 – Chart showing Demineralisation (ΔF) for all the surfaces combined. 
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7.0 Discussion 
 
In this section the results will be interpreted with an aim to outline the main strengths 
and limitations of this study. These limitations may have a direct effect on the internal 
and external validity which will also be discussed. Following the above the 
applicability of this research in the field of dentistry and areas of future research will 
also be outlined.  
 
The results defined the primary outcome assessing the effects of QScan use on 
plaque accumulation when compared to participants in the control group. The 
secondary outcome assessed the effects of QScan use on demineralisation when 
compared to participants in the control group.  
7.1 Interpretation 
 
The results were divided into the total effects on plaque accumulation as well as the 
effects on the defined segments (FAB, PL, F, A, B. P and L). This was done in an 
over three orthodontic visits. The results showed that there was a significant 
reduction in plaque accumulation following the collective assessment of all the 
segments with a p value of <0.001 from T0-T1. This was also apparent in from T1-T2 
(p<0.05) and finally when assessing the total effect throughout the research from T0-
T2 (p<0.001). This can be interpreted as a positive effect of QScan use. Patients that 
use the QScan can potentially benefit from a reduction in plaque which may 
theoretically have an effect on the adverse effects of plaque accumulation. However, 
this general effect on plaque reduction should be interpreted with caution, since this 
significant reduction was not apparent when the palatal segment was assessed 
independently. Though the frontal, buccal and palatal surfaces showed a significant 
reduction in plaque accumulation from T0-T2 this was not the case with the most 
difficult surface to use with QScan. The palatal surface showed an insignificant 
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difference in plaque accumulation when assessed at T0-T1, T1-T2 and T0-T2 
(p<0.05).  
One of the main adverse effects of plaque accumulation is demineralisation. This 
was assessed as the secondary outcome in the study. Unlike plaque accumulation 
demineralisation was not evident in all of the segments. Therefore, the areas of 
demineralisation were collectively assessed in all sections of the dentition (FABPL). 
Patients in the QScan group had an insignificant reduction of demineralisation when 
assessed at T0-T1, T1-T2 and T0-T2. 
7.2 Limitations 
 
Though statistically the results were significant as described, they must be 
interpreted with caution. Many limitations are apparent in this study. When assessing 
the recruitment process in detail, patients were all recruited from Liverpool University 
Dental Hospital which has a specific demographic of patients. This may potentially 
affect the generalisability of the study. There was an unequal number of males to 
females in both groups and no indication of socioeconomic status which has been 
shown to correlate with decayed, missing and filled teeth (DMFT) (Costa et al. 2012). 
They were all patients that currently had fixed orthodontic appliances and at different 
stages in their treatment. This may have an effect on their motivation to ensure 
adequate oral hygiene, with an expected reduction as the treatment progressed. 
Evidence has shown that increase in treatment duration has been associated with an 
increase in the development of white spot lesions (Khalaf 2014). Therefore, 
participants towards the end of their 2 year treatment would be expected to have 
more white spot lesions.  
 
The participants weren’t selected from a large sample but recruited consecutively at 
the start of the trial if they met the inclusion criteria. Most clinical trials follow this 
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method and recruit participants consecutively but they also ensure to randomly 
allocate them to groups in an aim to reduce confounding factors. This was also the 
case in this clinical trial. The patients were all treated by one investigator, though the 
oral hygiene instructions were standardised a risk of bias may appear to patients in 
one group or the other. The randomisation process was carried out by one 
investigator with the use of sealed envelopes. The same investigator allocated the 
participants to their groups and was therefore aware of which participants were in the 
QScan and control groups. This may subconsciously effect the management of 
these patients which may affect their oral hygiene. The stratification process though 
effective in ensuring that patients are equal in both groups with regards to 
demineralisation, it is however difficult to assess (Tranaeus et al. 2001). Patients 
with more than one area of demineralisation were considered high risk. Analysis with 
regards to demineralisation was completed on clinics to assign a patient to either 
being at high or low risk of demineralisation. This detailed analysis requires time 
which was limited, and therefore a generalised assessment was used rather than a 
detailed analysis on the number of demineralised areas. This may have affected the 
stratification process in this study.  
 
During the study areas of plaque accumulation were assessed after the fixed adjust 
treatment. This may have a direct effect on the amount of plaque present. 
Elastomeric modules are known to be plaque retentive and changing the modules in 
some of the cases may have reduced the amount of plaque. Though this was 
consistently done with all patients, it may have potentially benefitted patients with 
poor oral hygiene more than ones with adequate oral hygiene, reducing the overall 
plaque content. In addition, when certain mechanics are used during orthodontic 
treatment some teeth may be ligated with stainless steel ligatures rather than 
elastomeric ligatures. Evidence has shown that elastomeric modules are more 
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plaque retentive than stainless steel ligatures and therefore may have played a role 
in the overall plaque accumulation (Türkkahraman et al. 2015). Though the mode of 
ligation in all cases was mainly elastomeric, there was an assumption that only a few 
teeth in both groups would have other forms of ligation, and therefore no stratification 
was done in that regards. This may have potentially had an effect on the general 
outcome. 
 
The assessment of demineralisation requires all the plaque to be removed from the 
tooth surface. This is a long process in which not only plaque on the tooth surfaces 
must be removed but also around the fixed appliances. A small amount of plaque 
may alter the analysis in which if deemed as an area of demineralisation, would give 
a false positive. Areas of demineralisation and plaque accumulation following QLF-D 
photography are quite similar in their presentation. Therefore an area of plaque 
accumulation may be interpreted as an area of demineralisation and vice versa. 
Therefore any form of human error in the removal of plaque may have contributed to 
a false positive assessing demineralisation. The same scenario may occur when 
there are areas of staining and calculus which may also influence the QLF 
assessment. In an aim to overcome this, a detailed assessment of the white light 
images was completed prior to assessing the QLF photographs in an aim to remove 
any plaque present. This may be very difficult to do especially when pores of active 
demineralised sites are filled with plaque and other fluorescing substances 
(Tranaeus et al. 2001).  
 
Data collection using the QLF-D photographs requires an accurate assessment of 
tooth surfaces and ensuring that any other noise in the photos are emitted. In this 
study the photographs were taken with fixed appliances on. Any areas of 
demineralisation around the fixed appliance would need to be interpreted with 
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caution. A common mistake would be to include part of the bracket, module, wire or 
band into the area to be assessed. This would affect the final assessment of 
fluorescence and the comparison between demineralised enamel and sound 
enamel. Human error in placement of the outline not to include any pixels of the fixed 
appliances is not uncommon, especially when assessment is made on a pixel level. 
This complication may again lead to inaccurate assessment of demineralisation. This 
is not only apparent around the orthodontic appliance but also when an assessment 
is made near the gingival margin. Demineralisation near the gingival margin would 
require a very accurate outline of the area to be assessed. As with the fixed 
appliances any coverage of the gingivae in the demineralisation outline would affect 
ΔF. Another common issue with the assessment of demineralisation in orthodontic 
patients using QLF-D imaging is with teeth rotating during the alignment phase of 
treatment. As teeth rotate the angle in which the photograph is taken changes. This 
has the potential to effect the assessment of florescence loss aswell as the size of 
the lesion from one visit to the next (Van der Kaaij et al. 2018).   
 
Participants recruited in the study were fully aware of the outcomes to be assessed. 
When assessing plaque accumulation it is only a screenshot in time when the QLF-D 
photographs are taken. A participant may simply ensure to brush their teeth before 
the session. This would give an indication of adequate oral hygiene with reduced 
plaque levels in the photographs. However, the patient may have used the QScan 
device at home, but the device may not necessarily have had an impact on their 
plaque levels between their orthodontic appointments. The levels of plaque when the 
photos were taken may not necessarily represent the levels of plaque throughout the 
6-8 week period between the QLF-D photographs. The Hawthorne effect may have 
played a role in this clinical trial which can directly affect its generalisability 
(McCarney et al. 2007). Patients who were in the intervention group may have 
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ensured that their oral hygiene was adequate throughout the trail knowing that they 
were in a study to assess the effects of QScan.  
 
When a patient is provided with a new device especially in the average age range 
recruited in this study, they may go through a level of compliance at the start since it 
is a new device that they would aim to try out. This may soon fade away with time. 
This study was able to measure the changes over a short period of time when 
considering that orthodontic treatment may take up to 2-3 years in challenging 
cases. Due to the short period in which the study was conducted one cannot 
conclude that the effects of QScan in plaque accumulation may reduce plaque levels 
for orthodontic patients throughout their entire course of treatment.  
7.3 Strengths  
 
The study was conducted as a randomised control trial which aims to minimise bias, 
confounding factors with adequate statistical reliability (Rosner 2012). The 
investigators were blinded in which allocation to groups was conducted using sealed 
envelopes pre- prepared by investigator GB. In addition to random allocation the 
participants were also stratified in relation to the level of demineralisation. The 
patients in both groups were near equal in the average age and time between visits. 
The statistical analysis also revealed a non-statistically significant difference when 
assessing the difference in plaque accumulation between both groups at baseline. 
Therefore all measures were taken to ensure adequate randomisation and reduction 
of confounding factors.  
 
The investigators were blinded in relation the participants’ group allocation during 
data analysis. The photographs were labelled with random codes, and during 
analysis the photos were randomised once again to ensure limiting any recall of 
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patients and their assigned groups. The blinding was also completed throughout 
data analysis and only revealed once all the data was collected and presented to 
investigator GB for supervised statistical analysis.  
 
All the instruments used in the study were the same throughout. This is in relation to 
the camera used, the instruments used for plaque removal, the computer system to 
initially assess demineralisation for stratification as well as the QScan devices given 
to the patients. The settings on the camera and focal distance was consistent 
throughout, as well as the settings in the data analysis system to analyse plaque and 
demineralisation. This aimed to ensure consistency in the data collection and 
analysis.  
 
The participants had fixed orthodontic appliances and were at different stages of 
their treatment which as mentioned can be viewed as a limitation of the study. 
Though this may be interpreted differently. It may also be considered as a realistic 
use of an oral hygiene adjunct. Clinicians may advise their patients to use adjuncts 
at any stage of their treatment. The adjunct is usually recommended due to the 
patients’ inadequate oral hygiene status that may drop at any time during treatment. 
The short period in which the study was conducted averaged 15 weeks, which has 
also been defined as a limitation, though data from previous research (Ogaard & Ten 
Bosch 1994) revealed that demineralisation may appear in less than 4 weeks. A 15 
week period for such a study assessing a newly developed adjunct may provide the 
necessary information to further develop the device and its efficacy. A study with the 
same methodology may be done for a longer period though by the time it is 
completed, further alterations may have been made to the device. This has been 
evident with many oral hygiene adjuncts that are continuously being improved with 
new versions every year. If the data collection period is prolonged, upon completion 
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of the study there may be further developments of the QScan device which is 
currently available, and new/advanced versions maybe released. Therefore, labelling 
the trial as one which investigated a ‘dated/old’ version. Treatment in orthodontics 
may take up to 2 ½ - 3 years and therefore approximately 5 – 6 years to complete a 
study assessing plaque accumulation and demineralisation in patients prior to bond 
up until debond.  
7.4 Implications of results in practice 
 
The results of this study can have a considerate impact on clinical practice. As 
mentioned in the introduction the use of fixed orthodontic appliances makes the daily 
maintenance of oral hygiene much more of a challenge (Zachrisson & Zachrisson 
1971). Therefore orthodontists advise their patient of the main risks associated with 
orthodontic treatment which includes demineralisation. This is as a result of plaque 
accumulation around the appliances. Orthodontists may also advise their patients to 
use oral hygiene adjuncts in an aim to reduce the risks of demineralisation with 
adequate oral hygiene. QScan has shown to be an effective adjunct in the reduction 
of plaque accumulation in patients with orthodontic appliances. Therefore, this may 
be one of the options that an orthodontist may consider.  
 
During orthodontic treatment an orthodontist liaises with a number of clinicians in an 
aim to ensure that the patient has adequate oral hygiene throughout treatment. 
General dental practitioners, hygienists, therapists and orthodontic therapists can all 
play a role in ensuring patients have adequate oral hygiene throughout orthodontic 
treatment. Therefore, they may also advise patients about the use of QScan. This 
may be in conjunction with other oral hygiene adjuncts as well. 
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So far the clinical applications have been mentioned with regards to patients having 
fixed orthodontic appliances. This is not to say that the application of the device may 
not have an impact on patients without fixed appliances. During tooth brushing the 
areas of plaque accumulation are not only around the fixed appliances but also near 
the gum margin, interproximal, occlusal, lingual and palatal surfaces. All these 
surfaces were assessed during the study, and not only the labial and buccal surfaces 
where the fixed appliances were attached. Therefore the device has demonstrated to 
be effective on fixed appliance and non-fixed appliance surfaces. This may advocate 
the use of QScan in non-orthodontic patients in an aim to improve their oral hygiene. 
Whether these patients are aiming to have orthodontic treatment or not the 
application of such adjuncts may improve their oral hygiene. This has also been 
demonstrated in previous research (see applications of QScan in the literature 
review).  
 
Patients in the study mentioned that some of the main advantages in the use of 
QScan was the ability to clearly see the areas of plaque accumulation. The 
identification of plaque using QScan can be utilised by clinicians on clinic when 
providing oral hygiene instructions. Classically disclosing tablets were used with an 
aim to identify areas of plaque accumulation, which have their disadvantages 
(Hobson & Clark 1998). The main disadvantages described included staining of soft 
tissues, clothes and teeth rather than simply staining plaque. The patient information 
leaflets provided on the use of disclosing tablets have advised washing clothes or 
towels immediately if the red colouring is in contact with them (Endekay disclosing 
tablets erythrosine 2019). 
 
One of the other comments received by the participants was that the QScan device 
was utilised with younger members of the family. Participants with children used the 
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device in an aim to identify areas of plaque accumulation which may be difficult to do 
otherwise. Therefore, using the device as a tool to help them clean their children’s 
teeth better. Some participants also mentioned using the device to see whether their 
children who have recently been cleaning their teeth on their own, are being efficient 
and accurate in their tooth brushing. Though this research focussed mainly on 
assessing patients with fixed appliances and the efficiency of the QScan device, the 
device may have a number of other applications. The effectiveness of QScan use in 
these various applications may warrant further research.  
7.5 Future research applications 
 
The future research applications may be divided into a number of different aspects 
related to this particular study. These include, future research applications related to 
QScan, QLF-D and their use with and without fixed orthodontic appliances.  
 
7.5.1 Future research applications of QScan 
 
One of the future research applications of QScan following this research, would be a 
continuation of the work done in this study. A complete follow up of patients starting 
orthodontic treatment who are then assessed throughout their 2-3 year treatment for 
plaque accumulation and demineralisation. This can be beneficial especially if 
patients are followed up following debond of the fixed appliance. A comparison may 
be made between the pre orthodontic demineralisation, and post orthodontic 
demineralisation with or without QScan use. It may be considered not only beneficial 
to demonstrate the effects before and after treatment, but it may also reduce bias 
ascribed to a variation in the rate of deminerilsation and decay between individuals 
(Alanen 2000). This can also be expanded to assess gingival disease and the effects 
of QScan on periodontal status at different stages of orthodontic treatment, up to and 
following removal of the appliance. This research would however require a long 
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period of time to conduct, in which time further versions of QScan will be made with 
improvements to increase its level of efficiency.  
 
The QScan device as mentioned in section 7.4 of the discussion, may have a 
number of different applications. These can further be tested and researched. 
Starting off with patients using QScan without having fixed orthodontic appliances. 
This may or may not increase the effects of QScan on plaque accumulation. 
 
Other applications of QScan has been mentioned in relation to the use with children, 
where parents are able to identify areas they have missed when aiding their children 
to brush their teeth. A randomised control trial can assess levels of plaque 
accumulation where parents use the QScan device when brushing their children’s 
teeth. This can be compared with a control group where simple oral hygiene 
instructions are given.   
 
The application of QScan in a clinical setting by specialists, general dental 
practitioners, therapists, hygienists and nurses in conjunction with oral hygiene can 
be further tested. This can be done by assessing patients’ plaque levels when 
providing oral hygiene instructions with and without using QScan. This can also be 
assessed in relation to other measures of providing oral hygiene instructions. Verbal 
and video applications have been shown to be effective (Gray & McIntyre 2008) 
though never compared to educating patients with QLF applications or QScan. 
 
The alternative and most widely used plaque detector currently is the disclosing 
tablet. A survey concluded that 84% of British orthodontists are currently 
recommending the use of disclosing tablets (Hobson & Clark 1998). Patients are 
asked to use the disclosing tablets on a regular basis to ensure that they are efficient 
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in their tooth brushing. A future research project can be conducted as a three arm 
randomised control trial assessing three different groups. The first would be given 
the QScan device as the main intervention. The second group would be provided 
with disclosing tablets and the third would be the control group. This again can be 
assessed with patients having orthodontic appliances and patients that don’t.  
As mentioned in the clinical application of this research, in clinical practice 
practitioners may advise their patients on the use of oral hygiene adjuncts at any 
stage of their treatment. The question is which one is more effective? Oral hygiene 
instructions and its application must be customised to the patient and simplistic 
(British Society of Periodontology - The good practitioner’s guide to periodontology 
2016). Many adjuncts are currently available in the market. A randomised control trial 
comparing the effects of different adjuncts may be of benefit. Adjuncts may have 
different aims and one is recommended over another depending on what the patient 
struggles with, it would be valuable to have a list of adjuncts depending on patient 
specific struggles. For example, if patients are struggling with cleaning interdental 
areas a specific adjunct can be recommended vs patients struggling to clean areas 
around the gingivae or orthodontic brackets etc. Whether a disclosing tablet, 
interdental brush, water flosser, air flosser, electric toothbrush or QScan is a better 
adjunct for the various complications mentioned above. This may be assessed in 
relation to plaque accumulation, gingival health and demineralisation. One of the 
most reliable methods of detecting demineralisation is known to be QLF-D, which 
has a number of research applications aswell. 
7.5.2 Future research applications of QLF-D 
 
The use of QLF technology with an aim to detect demineralisation has been viewed 
as a reliable method (Benson 2003a). Therefore its applications can be in a number 
of different clinical and academic settings. The aim would be to assess the effects of 
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different interventions on demineralisation and plaque accumulation with the use of 
QLF-D technology. The interventions may vary between different adjuncts to oral 
hygiene that are currently available and others that are being developed.  
 
Demineralisation is one of the major adverse effects of poor oral hygiene and it may 
be considered as one of the most difficult adverse effects to assess. QLF technology 
has allowed demineralisation and plaque level assessment to be much more 
effective and efficient (Benson 2003a). Most research in the area of oral hygiene 
adjuncts has focused on plaque accumulation and gingival disease. Gingivitis can 
resolve due to its reversible nature though if demineralisation progresses further it 
may lead to cavities which will warrant restorations. Therefore it is important that if 
an adjunct is developed that it is assessed not only in relation to plaque 
accumulation but also in relation to demineralisation. An effective method as 
mentioned previously is with the use of QLF-D. 
 
The use of QLF-D may be used on its own as an adjunct to oral hygiene instructions. 
Clinicians can provide patients with oral hygiene advice following the use of QLF-D 
to highlight the areas of plaque accumulation. This can be done on a big screen in a 
clinic or simply on the QLF-D program using the computer screen. This may be 
considered for future research projects assessing OH instructions for patients with or 
without orthodontic appliances with the use of QLF-D.  
 
The recent advancements in technology has invited many dentists into the world of 
social media in an aim to aid in providing oral hygiene advice (Althunayan et al. 
2018). This may be considered as an adjunct to oral hygiene instructions. A 3 minute 
explanation on clinic though short may contain a lot of information for a patient to 
grasp. This information can be further reviewed on social media whether through 
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video applications, short clips or text. . This can be further assessed to see whether 
utilising social media can play a role in the improvement of patient’s oral hygiene. As 
with all QLF-D research this can be assessed in patients with or without fixed 
orthodontic appliances. 
8.0 Conclusion 
 
The use of QScan has demonstrated its effectiveness in the reduction of plaque 
accumulation. The significant reduction of plaque accumulation however did not 
translate to a reduction in demineralisation. This was evident after an average 15 
week assessment of orthodontic patients with fixed appliances. 
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10.Appendix 
 
Appendix 1: Fixed appliance starter pack components 
 
1. Three interdental brushes (Tepe™, Sweden). 
 
2. PlaqSearch™ (Tepe™, Sweden) four plaque disclosing tablets (to use at 
home to check to see if plaque remains after brushing). 
 
3. Orthodontic wax (to apply small piece to appliance should an area irritate 
the soft tissues). 
 
4. British Orthodontic Society patient information leaflet outlining ‘Fixed 
Appliances’. 
 
5. Colgate FluoriGard Alcohol Free Mouth Rinse 0.05% w/v sodium fluoride (to 
use once a day for 30 seconds at a different time than brushing) (Colgate™, 
United States). 
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Appendix 2: Images of Q-‐‐Scan device (front and back) 
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Appendix 3: Instructions on how to use the Q-‐‐Scan device at-home 
 
 
 
 
HOW DO I USE THE QSCAN DEVICE 
 
The Qscan device reveals the plaque on your teeth. 
 
Plaque: What is it?  
Plaque is a sticky, colourless film of bacteria that constantly forms on our teeth and causes tooth decay. 
 
Dental plaque is difficult to see unless it's stained. You can stain plaque by chewing red "disclosing tablets," 
found at supermarkets and chemists. The red colour left on the teeth will show you where there is still plaque—
and where you have to brush again to remove it.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, some people don’t like using disclosing tablets as it can be a bit time consuming and not everyone 
likes the taste of them. 
 
What if you could see a build up of plaque without disclosing tablets – well now you can! 
 
 
This device reveals the plaque without you having to use disclosing tablets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1  
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                                                          Normal light Qscan (showing bright red plaque)  
 
 
 
INSTRUCTIONS FOR USE 
 
x Use after brushing to see if all the plaque has been 
removed. (You should be brushing your teeth twice daily)  
x If red areas of plaque are visible, re-brush until it’s gone.  
x It’s easiest to the use the Qscan looking in a 
mirror. (See ‘Operating your Qscan’ on page 4) 
 
PARTS IDENTIFICATION  
 
 
 
 
 
 
 
 
 
                                                                                           
 
 
Power button (power on/off; control for LED 
mode light level)  
 
Charging port  
 
 
 
 
 
power supply  
adapter/charger (US)* 
 
*Or similar model 
 
 
 
 
 
2  
 
 
 
 
 
 
 
 
 
 
Optical Filter 
 
 LEDs 
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STORING CONDITIONS 
 
Should be used and stored at room temperature (32 to 86°F; 0 to 30°C), away from direct light and in a dry 
location. 
 
 
IMPORTANT SAFETY INFORMATION  
 
Keep this manual for future reference. It contains important information about maintenance and safe operation 
of your Qscan. 
 
x Do not disassemble the unit by force  
x Be careful not to scratch the filter  
x Be sure to turn off the power after using the product 
 
DANGERS 
 
x To avoid risk of damage to eyes or eyesight, never look directly into the light when the  
light is on, nor shine it directly into another person’s eyes  
x To reduce the risk of electrocution:  
x Do not place or store the product while charging in an area where it can fall or 
be pulled into a bath or sink, or where it will sit or drop into water or other liquid  
x Do not reach for a power supply adapter/charger that has fallen into water 
or other liquid. Unplug immediately.  
x Never use a power supply adapter/charger with a damaged cord or plug  
x Any battery may rupture or explode if put in a fire or otherwise exposed to excessive heat 
(direct sunlight, hot car). To avoid risk of injury, do not expose batteries to fire or 
excessive heat  
x Never short-circuit a battery pack by bringing the terminals in contact with a metal 
object. Explosion, burns, other bodily injury or fire could result. 
 
 
WARNINGS 
 
x This appliance is not intended for use by persons (including children) with reduced physical, 
sensory or mental capabilities, or lack of experience of knowledge, unless they have been 
given supervision or instruction concerning the use of the product by a person 
responsible for their safety 
x To reduce the risk of burns, electrocution, fire or physical injury: 
x Do not use any charging cradle, wall adapter, generic battery charger or  
other attachments other than those recommended by the manufacturer  
x This product is designed to be charged within a range of 100 to 240 volts  
x Never force the power supply adapter/charger plug into an outlet; if the plug 
does not easily fit into the outlet, discontinue use  
x Keep the product and power supply adapter/charger away from heated 
surfaces and liquids 
x This product is not a toy. Do not allow children or pets to play with your Qscan product.  
x Never force the plug into an electrical outlet; never force the power tip into the charging port x  
LEDs get hot during extended usage. Personal injury or damage to heat sensitive materials  
may result, e.g. plastics, rubber, cloth fabrics, etc. 
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x Do not use a cell phone power supply adapter/charger. Use only the 
power supply adapter/charger provided with your Qscan  
x The battery should be charged in a safe manner, and never overcharged or overdischarged.  
x Disconnect Qscan from the power supply adapter/charger once fully charged  
x If Qscan is to be stored unused for a long period of time, it should be charged up 
to 80% prior to storage 
 
 
 
CHARGING YOUR QSCAN 
 
Your Qscan features a built-in battery, which is not user replaceable. Tampering with your Qscan, or attempting 
to open it, will void the warranty and can result in a safety hazard. Use only the charger that was shipped with 
your product to charge the battery.  
1. Connect the Qscan to the power supply adapter/charger by inserting the power tip 
into the charging port  
2. Plug the charging cable into an electrical outlet  
3. The light on the charger is lit red while the Qscan is charging; the light on the charger will 
be lit green when the charging is complete 
4. It typically takes 2 hours to fully charge the Qscan 
5. Qscan should be disconnected from the charger once charging is complete 
 
 
OPERATING YOUR QSCAN 
 
You can use your Qscan before and after you brush your teeth, in order to show how effectively you’ve 
cleaned your teeth. Your Qscan will work best in a low lit area. 
 
Self Use:  
1. While facing a mirror and with the Qscan off, with the LED strip on the bottom of 
the Qscan facing toward you, point the LEDs directly toward your mouth  
2. Turn on the Qscan by pressing the power button. If power button is pressed once, the LEDs 
will be operating on HIGH level; if power button is pressed twice, the LEDs will be operating 
on LOW level; if power button is pressed a third time, the Qscan will be turned off.  
3. While looking directly into the mirror, view the reflection of your mouth through the 
optical filter in the Qscan for visible signs of red fluorescence, which would indicate 
areas on your teeth that require additional self cleaning or, if red fluorescence persists, 
you may want to consider a professional cleaning. 
 
CLEANING YOUR QSCAN 
 
1. Use lens cleaning cloth to clean the Qscan filter. The casing can be cleaned with a 
damp cloth with mild detergent  
2. Do not use isopropyl rubbing alcohol, vinegar, or essential oil based products to 
clean the Qscan  
3. Do not clean the Qscan in the dishwasher 
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Appendix 4: Participant information sheet for 11-13yrs 
 
 
 
 
 
 
 
 
 
 
 
 
INFORMATION SHEET FOR 11-13 yrs 
 
The use of the Q-Scan device as an adjunct to “at-home” oral 
hygiene in Orthodontics 
 
We want to tell you about a research study we are doing. A research study is a 
special way to find out about something. We would like you to join this study that 
looks at how clean your teeth are. Before you decide please read this information 
sheet. 
 
We will be using a camera that records a photograph of your teeth. This camera 
takes a two photographs, a normal and a blue light photograph of the teeth. It will 
help us see how clean your teeth are. You will be given tooth brushing advice and 
shown the blue light photographs. These photographs will show you if you are 
missing any areas.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some people who choose to take part will be given a device to use at home to check 
their tooth brushing. By pressing a simple on/off button you can highlight the teeth and 
using a mirror can see any plaque that’s there as it will be red in colour. You can then 
go back and brush your teeth again to remove this. Only half of the people who take 
part in the study will be given one of these to use. Everyone who takes part will have the 
photographs taken to show them how their cleaning is and to give them tips on how to 
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improve their cleaning around the braces. These photos will only be used for the study, 
and your name will not be attached to them or mentioned (codes will 
be used instead of your name). They will be kept safe so that no one can see them 
except the dentists doing the study. The photos will be deleted 11 years after the 
study is done though will not be reused unless your permission is taken. 
 
The study will not change your treatment. It will only make 5 of your appointments 
about 5 minutes longer. 
 
What is the purpose of the study?  
We would like to find out if the device (called Q-Scan) helps people with braces to 
clean their teeth better at home. 
 
Q- Scan device:  
 
 
 
 
 
 
 
 
 
 
 
 
 
Why have I been asked to take part? 
You are the right age and are going to have upper and lower braces fitted. 
 
What will happen if I say yes and what will happen during the study?  
We will take the special QLF-D photographs when the braces have been fitted and 
at two check-up sessions after that. If we need to we will clean the teeth at these 
review appointments. We will show you the photographs and give you tooth 
brushing advice to focus on any areas that need better cleaning.  
Half of the people that choose to take part will be given a Q-Scan device to take 
home and use twice a day after brushing. This will need to be brought to each 
review appointment so the dentist can check it is working. After treatment is finished 
and braces are removed you will be asked to give this device back to the dentist. 
 
How long is the project? 
It will last for four sessions in total. 
 
What if I am not happy or have a problem?  
You can stop taking part in this project at any time. Your brace treatment 
will continue as normal. 
 
What if the Q-Scan device breaks?  
If the Q-Scan breaks please stop using it, pack it away carefully and contact me to 
arrange to come into the clinic so we can see what the problem is (please see 
contact details below). It is important to keep in a safe place and ask your parent 
on which place is best so that it does not break. 
 
What if I have a question? 
If you have any questions, feel free to ask and I will be happy to answer them. 
Thank you for taking the time to read this.  
Contact email: qscan@liv.ac.uk  Phone: 0044 (0)151 706 525
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Appendix 5: Participant information sheet for 14-15yrs 
 
 
 
 
 
 
 
INFORMATION SHEET FOR 14-15 yrs 
 
The use of the Q-Scan device as an adjunct to “at-home” oral hygiene in 
Orthodontics 
 
We want to tell you about a research study we are doing. A research study is a 
special way to find out about something. We would like you to join this study that 
looks at how clean your teeth are. Before you decide please read this information 
sheet. Please ask us if there is anything that is not clear or you have any questions. 
 
Quantitative Light Induced Fluorescence digital (QLFD
TM
) is a 
camera which records a photograph of your teeth. This camera 
takes a normal photograph and a blue light photograph of the 
teeth. It will help us monitor your teeth and see how clean they 
are. If there is plaque on your teeth we will be able to see it. You 
will be given tooth brushing advice and shown the blue light 
photographs. These photographs will show the areas of plaque 
on your teeth and help you know where to brush.  
 
Some people who choose to take part will be given a device to use at home to check 
their tooth brushing. By pressing a simple on/off button you can highlight the teeth 
and using a mirror can see any plaque that’s there as it will be red in colour. You can 
then go back and brush your teeth again to remove this. Only half of the people who 
take part in the study will be given one of these to use. Everyone who takes part will 
have the photographs taken to show them how their cleaning is and to give them tips 
on how to improve their cleaning around the braces. These photos will only be used 
for the study, and your name will not be attached to them or mentioned (codes will 
be used instead of your name). They will be secured so that no one has access to 
them except the dentists doing the study. The photos will be disposed of 11 years 
following the study completion though will not be reused unless your permission is 
taken. 
 
The study will not change your treatment. It will only make 5 of your appointments 
about 5 minutes longer. 
 
What is the purpose of the study?  
We would like to find out if the device (called Q-Scan) helps people with braces to 
clean their teeth better at home. 
 
We will be using a Quantitative Light Induced Fluorescence-Digital (QLF-DTM) 
camera to take normal and blue light photographs of your teeth when you are in 
the clinic. We will be trying to find the areas where plaque as not been cleaned 
away or where there is any minor damage to your teeth. 
 
We are aiming to find out if showing you the camera photographs, or if the use of the 
device at home, is useful for your tooth brushing. At the end of your brace treatment 
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we will ask you to complete a questionnaire to assess how useful you feel the 
photographs / Q-Scan device were. 
 
Q- Scan device:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Why have I been asked to take part? 
You are the right age and are going to have upper and lower braces fitted. 
 
What will happen if I say yes?  
We will take the special QLF-D photographs when your braces have been fitted and 
in 2 check ups visits following that. If we need to we will clean the teeth at these 
review appointments. We will show you the photographs and give you tooth brushing 
advice to focus on any areas that need better cleaning. Half of the people that 
choose to take part will be given a Q-Scan device to take home and use twice a day 
after brushing. This will need to be brought to each review appointment so the 
dentist can check it is working. After treatment is finished and braces are removed 
you will be asked to give this device back to the dentist. 
 
How long is the project? 
It will last for the same amount of time as your fixed brace treatment. 
 
What if I am not happy or have a problem?  
You can stop taking part in this project at any time. Your brace treatment 
will continue as normal. 
 
What if the Q-Scan device breaks?  
If the Q-Scan breaks please stop using it, pack it away carefully and contact me 
to arrange to come into the clinic so we can see what the problem is (please see 
contact details below). 
 
What if I have a question? 
If you have any questions, feel free to ask and I will be happy to answer them. 
 
Thank you for taking the time to read this. 
 
Contact email: qscan@liv.ac.uk 
Phone: 0044 (0)151 706 5252 
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Appendix 6: Participant information sheet for over 16yrs 
 
 
 
 
 
 
 
 
INFORMATION SHEET FOR THE PARTICIPANT (16 and over) 
 
 
The use of the Q-Scan device as an adjunct to “at-home” oral hygiene in Orthodontics 
 
You are being asked to participate in a research project, which is looking at a new way to 
help people with braces check their tooth brushing at home. People who decide to take part 
will be divided into two groups. One group will be given a hand held device (named Q-Scan) 
to take home and asked to use it twice daily to check their teeth after brushing. The other 
group will not be given a device. 
 
Before deciding whether to take part in the study please take a little time to read this 
information sheet. Please ask us if there is anything that is unclear, if you have any 
questions or would like further information. 
 
What is the purpose of the study?  
Our aim is to find out if the Q-Scan device helps people with braces clean their teeth at-
home. We also want to find out if the blue and white light photographs taken with a special 
digital camera help people with braces keep their teeth clean. 
 
How will the study work?  
In the Orthodontic clinic both groups will have photographs taken of their teeth in order to 
assess the level of cleanliness and also to identify areas which show early signs of minor 
damage which can appear like white spots on the teeth. 
 
Quantitative Light Induced Fluorescence digital (QLFDTM) is a digital camera which takes a 
normal photograph and a blue light photograph of the teeth. The blue light enables plaque to 
be seen as red areas on teeth. It is also able to show early enamel changes, which can 
leave permanent marks on teeth, at an earlier stage than eye sight alone. In this study both 
groups will have QLF-D photographs taken when the braces have been fitted and at two 
subsequent check-up visits. Taking clinical photographs is part of the normal course of 
Orthodontic treatment. Taking part in the study will lengthen your appointment time by 
approximately 5 minutes on 5 occasions. You will not be required to attend extra 
appointments. The photos will only be used for the study, and your name will not be 
attached to them or mentioned (codes will be used instead). They will be secured so 
that no one has access to them except the dentists doing the study. The photos will 
be disposed of 11 years following the study completion though will not be reused 
unless your permission is taken. 
 
 
One group will be given the Q-Scan device to use at home. This device uses the same 
technology as the QLFD camera, allowing the person using it to check if there is any plaque 
on their teeth after brushing by simply turning the device on and looking in a mirror. Any 
areas with plaque still present will appear red. The participant will then need to brush 
their teeth again to remove the red area (plaque) to make sure the teeth are 
completely clean. After your braces have been removed the device will need to be given 
back to the Orthodontic Department. 
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The other group will not be given the Q-Scan device and will be asked to clean their teeth as 
they normally do. 
 
Has the study been approved?  
Ethical approval via IRAS has been completed. 
 
Who is paying for the study?  
The University of Liverpool will be funding this project. 
 
Who will be conducting the study?  
The study is being run by Dr Norah Flannigan (Senior Clinical Lecturer in Orthodontics) and 
a Postgraduate in Orthodontics (Salman Sarkhouh). The study will be done as part of a 
postgraduate program in orthodontics. 
 
Why have I been asked to take part?  
You have been asked to take part because we are looking for healthy volunteers aged 11-
years or older who will be having upper and lower fixed braces. 
 
How long will the study last?  
The study will last for as long as the fixed brace treatment takes. The study ends when the 
braces are removed. However, should you wish to withdraw from the study you may do so at 
any stage and your Orthodontic care will continue as normal. 
 
What if I do not want to take part?  
Your treatment will continue as normal. You should not feel obliged to take part and you do 
not have to give a reason if you do not want to. If you do take part in the study, but later 
decide that you do not want to continue you can also withdraw at any time without giving a 
reason. 
 
What if I have a question or if there is a problem during the study?  
You may ask questions at any time, before and during the study. If you wish to make any 
enquiry, you may contact, the Orthodontic Department, Liverpool University Dental Hospital, 
Pembroke Place, Liverpool, L3 5PS. Email: qscan@liv.ac.uk. 
 
If you have a concern about any aspect of this study, you should ask to speak to a member 
of the research team on 0044 (0)1517065252. They will do their best to answer your 
questions. If you are still unhappy and wish to complain formally, you can do this through the 
Patient Advice Liaison Service or by emailing; complaints@rlbuht.nhs.uk. 
 
It must be noted that it is important to keep the device in a safe place and ensure to follow 
the “How do I use the QScan device” document. The device should be monitored and if 
there are any problems with the device it is important to contact for advice or possible repair. 
 
How will the information collected be managed?  
Information about you will be stored anonymously. As soon as we have collected the 
information, we will replace any personal information with a code. The person responsible 
for security and access to your data is Dr Flannigan, the Chief investigator of the Study. 
 
What do I do if I want to take part?  
If you would like to take part, please sign all the relevant sections of the consent form that 
you will have been provided with. 
 
 
 
Thank you for taking the time to read this. 
Email: qscan@liv.ac.uk  
Phone: 0044 (0)151 706 5252
 
 
 
133 
 
Appendix 7: Information sheet for parents 
 
 
 
 
 
 
 
 
 
 
 
INFORMATION SHEET FOR THE PARENT 
 
The use of the Q-Scan device as an adjunct to at home oral hygiene in Orthodontics 
 
Your child has been asked to participate in a research project which is:  
1. Investigating if a new device (named Q-Scan) can help patients with fixed 
braces improve their “at-home” tooth brushing. One group will be given the Q-
Scan device to use at home in addition to their normal oral hygiene advice. 
The other group will not receive the device but will still receive the normal oral 
hygiene instructions that are given to all patients with braces.  
2. Both groups will have special photographs taken of their teeth when they 
attend the clinic. These photographs will be taken when the braces have been 
fitted and in the subsequent two check-up visits. In addition to providing 
information for the research, these images will be used to teach the patients 
about how to improve their tooth brushing skills. 
 
Before deciding whether to take part in the study please take a little time to read this 
information sheet. Please ask us if there is anything that is unclear, if you have any 
questions or would like further information. 
 
What is the purpose of the study?  
Our aim is to find out if the Q-Scan device helps people with braces clean their teeth 
at home. We also want to find out if the blue and white light photographs taken with a 
special digital camera help people with braces keep their teeth clean. 
 
How will the study work?  
In the Orthodontic clinic participant will have photographs taken of their teeth in order 
to assess the level of cleanliness and also to identify areas which show early signs of 
minor damage which can appear like white spots on the teeth. 
 
Quantitative Light Induced Fluorescence Digital (QLFDTM) is a digital camera which 
takes a normal photograph and a blue light photograph of the teeth. The blue light 
enables plaque to be seen as red areas on teeth. It is also able to show early enamel 
changes, which can leave permanent marks on teeth, at an earlier stage than eye 
sight alone. In this study both groups will have these photographs taken when the 
braces have been fitted and in the following two subsequent check-up visits. Taking 
clinical photographs is part of the normal course of Orthodontic treatment and; taking 
part in the study will require a couple of extra minutes per appointment for the QLFD 
photographs to be taken in addition to the regular photographs. You will not be 
required to attend extra appointments. These photos will only be used for the study, 
and your name will not be attached to them or 
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mentioned (codes will be used instead). They will be secured so that no one has 
access except the dentists doing the study. The photos will be disposed of 11 years 
following the study completion though will not be reused unless your permission is 
taken. 
 
Your child will be assigned to one of two groups. One group will be given the Q-Scan 
device to use at home. This device uses the same technology as the QLFD camera, 
allowing the person using it to check if there is any plaque on their teeth after 
brushing by simply turning the device on and looking in a mirror. Any areas with 
plaque still present will appear red. The participant will then need to brush their 
teeth again to remove the red area (plaque) to make sure the teeth are 
completely clean. After your braces have been removed the device will need to be 
given back to the Orthodontic Department. 
 
The other group will not be given the Q-Scan device and will be asked to clean their 
teeth as they normally do. 
 
There is no harmful risk to the use of the Q- Scan device and it is to be used in the 
morning and evening after brushing their teeth. Your child will be advised of this if 
the decision has been made to take part. 
 
Has the study been approved? 
Ethical approval via IRAS has been completed. 
 
Who is paying for the study? 
The University of Liverpool will be funding this project. 
 
Who will be conducting the study?  
The study is being led by Dr Norah Flannigan (Senior Clinical Lecturer in 
Orthodontics) and a Specialist Registrar in Orthodontics (to be appointed). 
 
Why has my child been asked to take part?  
We are looking for healthy volunteers, 11 years of age or older, who are planned for 
upper and lower fixed braces. 
 
What will happen if my child takes part?  
They will be assigned to one of two groups. One group will receive the Q-Scan 
device to use at home. The other group will receive the usual oral hygiene advise but 
will not be given a device. All of the participants will have the special blue and white 
light photographs taken at 4 different appointments during their brace treatment. 
Your child’s teeth will also be given a clean if required. This will lengthen the 
appointment time by approximately 5 minutes on 5 occasions. At the end of the 
study we will ask your child to complete a questionnaire to assess how useful the 
study has been to your child. Taking part in the study will not require any extra 
appointments. 
 
How long will the study last?  
The study will last for as long as the fixed brace treatment takes. The study ends 
when the braces are removed. However, should you or your child wish to withdraw 
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from the study you may do so at any stage and their Orthodontic care will continue 
as normal. 
 
What if I do not want my child to take part?  
Your child’s treatment will continue as normal. You should not feel obliged to consent 
to taking part in you do consent but later decide that you do not want to continue you 
can also withdraw at any time without giving a reason. 
 
 
 
 
What if I have a question of there is a problem during the study?  
You may ask questions at any time, before and during the study. If you wish to make 
any enquiry, you may contact, the Orthodontic Department, Liverpool University 
Dental Hospital, Pembroke Place, Liverpool, L3 5PS. Email: qscan@liv.ac.uk. 
 
If you have a concern about any aspect of this study, you should ask to speak to a 
member of the research team on +44 (0)1517065252. They will do their best to 
answer your questions. If you are still unhappy and wish to complain formally, you 
can do this through the Patient Advice Liaison Service or by emailing; 
complaints@rlbuht.nhs.uk. 
 
How will the data collected be managed?  
Information about participants will be stored anonymously. As soon as we have 
collected the information, we will replace any personal information with a code. The 
person responsible for security and access to the data is Dr Flannigan, the Chief 
investigator of the Study. 
 
What do I do if I am happy for my child to take part?  
If you are happy for your child to take part, please sign all the relevant sections of the 
consent form that you will have been provided with. 
 
Thank you for taking the time to read this. 
 
Email: qscan@liv.ac.uk 
Tel: +44 (0)1517065252 
this udy and o not have to give a reason if you do not want to. If 
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Appendix 8: Consent form 1 – Patients agreement for participation in 
research under 16 
 
 
 
 
 
 
 
Patient Identification Number for this trial: 
 
CONSENT FORM 1 
Patient’s agreement for participation in research 
Under 16 
 
 
 
Research project: 
 
 
 
The use of the Q-Scan device as an adjunct to “at-home” 
Orthodontics 
 
 
 
oral hygiene in 
 
Researcher: 
 
Dr Norah Flannigan 
 
Please initial box 
 
 
1. I confirm that I have read and understood the information 
sheet dated 10/10/2017 (Version 1.4) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected. 
 
 
3. I understand that the data collected during the study will be 
analysed by the study investigators and that relevant sections 
of data may be looked at by individuals from regulatory 
authorities, where it is relevant to my taking part in this 
research. I give permission for these individuals to have 
access to my records.  
 
 
4. I agree to take part in the above study. 
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Appendix 9: Consent form 2 – Patients agreement for participation in 
research over 16 
 
 
 
 
 
 
 
Patient Identification Number for this trial: 
 
CONSENT FORM 2 
Patient’s agreement for participation in research 
Over 16 
 
 
 
Research project: 
 
 
 
The use of the Q-Scan device as an adjunct to “at-home” 
Orthodontics 
 
 
 
oral hygiene in 
 
Researcher: 
 
Dr Norah Flannigan 
 
Please initial box 
 
 
1. I confirm that I have read and understood the information 
sheet dated 10/10/2017 (Version 1.4) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected. 
 
 
3. I understand that the data collected during the study will be 
analysed by the study investigators and that relevant sections 
of data may be looked at by individuals from regulatory 
authorities, where it is relevant to my taking part in this 
research. I give permission for these individuals to have 
access to my records.  
 
 
4. I agree to take part in the above study. 
 
 
 
 
__________________________ ____________ ______________________ 
Name of Volunteer Date Signature 
__________________________ ____________ ______________________ 
Name of Person Date Signature 
taking consent   
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Appendix 10: Consent form 3 – Parental agreement for participation in 
research 
 
 
 
 
 
 
 
 
Patient Identification Number for this trial: 
 
CONSENT FORM 3  
Parental agreement for participation in research 
 
 
 
Research project: 
 
 
 
The use of the Q-Scan device as an adjunct to “at-home” 
Orthodontics 
 
 
 
oral hygiene in 
 
Researcher: 
 
Dr Norah Flannigan 
 
Please initial box 
 
 
1. I confirm that I have read and understood the information 
sheet dated 10/10/2017 (Version 1.4) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2. I understand that my child’s participation is voluntary and that I 
am free to withdraw them at any time without giving any 
reason, without their medical care or legal rights being 
affected. 
 
 
3. I understand that the data collected during the study will be 
analysed by the study investigators and that relevant sections 
of data may be looked at by individuals from regulatory 
authorities, where it is relevant to my child’s taking part in this 
research. I give permission for these individuals to have 
access to my child’s records.  
 
 
4. I agree to my child taking part in the above study. 
 
 
 
 
__________________________ ____________ ______________________ 
Parent / Guardian Date Signature 
__________________________ ____________ ______________________ 
Name of Person Date Signature 
taking consent   
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Appendix 11: Debriefing questionnaire 
 
 
 
 
 
 
 
 
 
Patient Identification Number for this trial: 
 
Debriefing questionnaire 
 
 
 
Research project: 
 
 
 
The use of the Q-Scan device as an adjunct to “at-home” 
Orthodontics 
 
 
 
oral hygiene in 
 
Researcher: 
 
Dr Norah Flannigan 
 
We would be grateful if you can provide us with the following information 
 
Please initial box 
 
 
1. How many times a day on average are you using the 
QScan device? 
 
2. How many days a week on average are you using the 
QScan device?  
 
3.  For  how  many  weeks/  days  have  you  been  using  the 
/ device? 
 
 
 
 
__________________________ ____________ ______________________ 
Name of Volunteer Date Signature  
 
 
 
 
Admin use - number of weeks/days since device was given / 
  
Views sheet: 
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Appendix 12: Ethical approval 
 
 
 
 
North West - Liverpool Central Research Ethics Committee  
3rd Floor 
Barlow House 
4 Minshull Street  
Manchester  
M1 3DZ 
 
Telephone: 020 71048008  
 
Please note: This is the  
favourable opinion of the 
REC only and does not allow 
you to start your study at NHS  
sites in England until you 
receive HRA Approval  
 
 
08 February 2017 
 
Dr Norah Flannigan  
Liverpool University Dental Hospital  
Pembroke Place 
Liverpool 
L3 5PS 
 
 
Dear Dr Flannigan 
 
Study title: 
 
 
 
 
 
 
 
 
REC reference:  
Protocol number:  
IRAS project ID: 
 
The use of the Q-Scan oral hygiene device for plaque  
identification as part of an "at-home" oral hygiene 
routine and to assess its influence on plaque 
accumulation and enamel demineralisation using the 
QLF-Dâ„¢ (Quantitative Light Induced Fluorescence- 
Digitalâ„¢) in patients undergoing fixed appliance 
orthodontic treatment at Liverpool University Dental 
Hospital.  
16/NW/0695  
UoL001233 
210553 
 
Thank you for responding to the Committee’s request for further information on the 
above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter. Should you wish to provide a substitute contact point, require further 
information, or wish to make a request to postpone publication, please contact 
hra.studyregistration@nhs.net outlining the reasons for your request. 
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Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to the start 
of the study. 
 
Management permission must be obtained from each host organisation prior to the start of 
the study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given permission 
for the research to proceed (except where explicitly specified otherwise). 
 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.  
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with 
the procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from 
host organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and 
publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details as part of 
the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they 
should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be 
registered, however, in exceptional circumstances non registration may be permissible with prior 
agreement from the HRA. Guidance on where to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable). 
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Ethical review of research sites 
 
NHS sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of the 
study (see "Conditions of the favourable opinion" below). 
 
Non-NHS sites 
 
The Committee has not yet completed any site-specific assessment (SSA) for the non-NHS 
research site(s) taking part in this study. The favourable opinion does not therefore apply to any 
non-NHS site at present. We will write to you again as soon as an SSA application(s) has been 
reviewed. In the meantime no study procedures should be initiated at non-NHS sites. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
Document Version 
 
Date 
 
  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors      
only)      
IRAS Application Form [IRAS_Form_12092016]   12 September 2016  
      
IRAS Application Form XML file [IRAS_Form_12092016]   12 September 2016  
      
Non-validated questionnaire [Debriefing] 1.2  07 February 2017  
      
Other [CE evidence for Q-Scan device]   28 March 2016  
      
Other [user manual]      
      
Participant consent form [under 16] 1.2  07 February 2017  
      
Participant consent form [over 16] 1.2  07 February 2017  
      
Participant consent form [parent] 1.2  07 February 2017  
      
Participant information sheet (PIS) [11-13] 1.2  07 February 2017  
      
Participant information sheet (PIS) [14-15] 1.2  07 February 2017  
      
Participant information sheet (PIS) [over 16] 1.2  07 February 2017  
      
Participant information sheet (PIS) [Parent] 1.2  07 February 2017  
      
Referee's report or other scientific critique report [Peer review form   10 June 2016  
1]      
Referee's report or other scientific critique report [Peer review form   10 June 2016  
2]      
Research protocol or project proposal 1.1  06 August 2016  
      
Summary CV for Chief Investigator (CI) [CI CV] V1.1  10 June 2016  
      
Summary CV for student      
      
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
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The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments

 Adding new sites and investigators

 Notification of serious breaches of the protocol

 Progress and safety reports

 Notifying the end of the study
 
 
The HRA website also provides guidance on these topics, which is updated in the light 
of changes in reporting requirements or procedures. 
 
User Feedback 
 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the feedback 
form available on the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality-
assurance/ 
 
HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days – see details 
at http://www.hra.nhs.uk/hra-training/  
 
16/NW/0695 Please quote this number on all correspondence  
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely  
 
 
 
 
 
 
 
 
Mrs Julie Brake  
Chair 
 
Email:nrescommittee.northwest-liverpoolcentral@nhs.net 
 
Enclosures: “After ethical review – guidance for  
researchers 
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Dr Norah Flannigan  
Liverpool University Dental Hospital Email: hra.approval@nhs.net  
Pembroke Place     
Liverpool     
L3 5PS     
16 February 2017     
Dear Dr Flannigan     
    
  Letter of HRA Approval   
    
Study title: The use of the Q-Scan oral hygiene device for plaque 
 identification as part of an "at-home" oral hygiene routine 
 and to assess its influence on plaque accumulation and 
 enamel demineralisation using the QLF-Dâ„¢ (Quantitative 
 Light Induced Fluorescence-Digitalâ„¢) in patients 
 undergoing fixed appliance orthodontic treatment at 
 Liverpool University Dental Hospital.  
IRAS project ID: 210553   
Protocol number: UoL001233  
REC reference: 16/NW/0695  
Sponsor University of Liverpool  
 
 
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter. 
 
 
Participation of NHS Organisations in England 
 
The sponsor should now provide a copy of this letter to all participating NHS organisations in England. 
 
 
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, 
in particular the following sections: 
 
 Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
 activities 
 Confirmation of capacity and capability - this confirms whether or not each type of participating 
NHS organisation in England is expected to give formal confirmation of capacity and capability. 
Where formal confirmation is not expected, the section also provides details on the time limit given to 
participating organisations to opt out of the study, or request additional time, before their participation 
is assumed.
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 Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) - this provides detail on the form of agreement to be used in the study to confirm capacity 
and capability, where applicable. 
 
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
 
 
It is critical that you involve both the research management function (e.g. R&D office) supporting 
each organisation and the local research team (where there is one) in setting up your study. Contact 
details and further information about working with the research management function for each 
organisation can be accessed from www.hra.nhs.uk/hra-approval. 
 
 
Appendices 
 
The HRA Approval letter contains the following appendices: 
 
   A – List of documents reviewed during HRA assessment
 B – Summary of HRA assessment 
 
After HRA Approval 
 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your  
REC favourable opinion, gives detailed guidance on reporting expectations for studies, including: 
 
   Registration of research
  Notifying amendments
  Notifying the end of the study 
 
The HRA website also provides guidance on these topics, and is updated in the light of changes 
in reporting expectations or procedures. 
 
 
In addition to the guidance in the above, please note the following: 
 
 HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 

 notified in writing by the HRA.
g)  Substantial amendments should be submitted directly to the Research Ethics Committee, as  
  detailed in the After Ethical Review document. Non-substantial amendments should be 
  submitted for review by the HRA using the form provided on the HRA website, and emailed to 
  hra.amendments@nhs.net.    
     
 h)  The HRA will categorise amendments (substantial and non-substantial) and issue confirmation 
  of continued HRA Approval. Further details can be found on the HRA website. 
       
 
Scope 
 
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England. 
 
 
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
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If there are participating non-NHS organisations, local agreement should be obtained in 
accordance with the procedures of the local participating non-NHS organisation. 
 
 
User Feedback 
 
The Health Research Authority is continually striving to provide a high quality service to all applicants and 
sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please email the HRA at hra.approval@nhs.net. 
Additionally, one of our staff would be happy to call and discuss your experience of HRA Approval. 
 
 
HRA Training 
 
We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/ 
 
 
Your IRAS project ID is 210553. Please quote this on all correspondence. 
 
 
Yours sincerely 
 
 
Dr Claire Cole 
 
Senior Assessor 
 
 
Email: hra.approval@nhs.net 
 
 
 
 
 
 
Copy to: Mr Alex Astor 
Prof Rebecca Harris, The University of Liverpool 
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Appendix A - List of Documents 
 
 
The final document set assessed and approved by HRA Approval is listed below. 
 
 
Document Version  Date  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors      
only)      
IRAS Application Form [IRAS_Form_12092016]   12 September 2016  
      
IRAS Application Form XML file [IRAS_Form_12092016]   12 September 2016  
      
Non-validated questionnaire [Debriefing] 1.3  15 February 2017  
      
Other [user manual]      
      
Other [Statement of Activities] 1.0  08 February 2017  
      
Other [Schedule of Events] 1.0  08 February 2017  
      
Other [CE evidence for Q-Scan device]   28 March 2016  
      
Participant consent form [over 16] 1.3  15 February 2017  
      
Participant consent form [parent] 1.3  15 February 2017  
      
Participant consent form [under 16] 1.3  15 February 2017  
      
Participant information sheet (PIS) [11-13] 1.3  15 February 2017  
      
Participant information sheet (PIS) [14-15] 1.3  15 February 2017  
      
Participant information sheet (PIS) [over 16] 1.3  15 February 2017  
      
Participant information sheet (PIS) [Parent] 1.3  15 February 2017  
      
Referee's report or other scientific critique report [Peer review form   10 June 2016  
1]      
Referee's report or other scientific critique report [Peer review form   10 June 2016  
2]      
Research protocol or project proposal 1.1  06 August 2016  
      
Summary CV for Chief Investigator (CI) [CI CV] V1.1  10 June 2016  
      
Summary CV for student      
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Appendix B - Summary of HRA Assessment 
 
 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix. 
 
The following person is the sponsor contact for the purpose of addressing participating 
organisation questions relating to the study: 
 
 
Name: Mr Alex Astor 
 
Tel: 01517948739 
 
Email: sponsor@liv.ac.uk 
 
 
 
HRA assessment criteria 
 
Section HRA Assessment Criteria  Compliant with  Comments 
   Standards  
     
1.1 IRAS application completed  Yes No comments 
 correctly     
     
     
2.1 Participant information/consent  Yes The information sheets, consent forms 
 documents and consent    and non-validated questionnaire have 
 process    been changed to comply with HRA 
     standards. These changes are non- 
     substantial therefore have not been 
     submitted for REC review. 
     
     
3.1 Protocol assessment  Yes No comments 
     
     
4.1 Allocation of responsibilities  Yes A statement of activities will act as the 
 and rights are agreed and    agreement between the sponsor and 
 documented    the site. 
     Schedule of Events has been submitted 
     which does not have any cost 
     attributions completed. 
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Section HRA Assessment Criteria  Compliant with   Comments 
   Standards    
      
4.2 Insurance/indemnity  Yes Where applicable, independent 
 arrangements assessed    contractors (e.g. General Practitioners) 
     should ensure that the professional 
     indemnity provided by their medical 
     defence organisation covers the 
     activities expected of them for this 
     research study  
      
4.3 Financial arrangements  Yes No funding provided to sites as detailed 
 assessed    in the Statement of Activities. 
      
      
5.1 Compliance with the Data  Yes No comments  
 Protection Act and data       
 security issues assessed       
      
5.2 CTIMPS – Arrangements for  Not Applicable No comments  
 compliance with the Clinical       
 Trials Regulations assessed       
      
5.3 Compliance with any  Not Applicable No comments  
 applicable laws or regulations       
      
       
6.1 NHS Research Ethics  Yes No comments  
 Committee favourable opinion       
 received for applicable studies       
      
6.2 CTIMPS – Clinical Trials  Not Applicable No comments  
 Authorisation (CTA) letter       
 received       
      
6.3 Devices – MHRA notice of no  Not Applicable No comments  
 objection received       
      
6.4 Other regulatory approvals  Not Applicable No comments  
 and authorisations received       
        
 
 
Participating NHS Organisations in England  
 
This provides detail on the types of participating NHS organisations in the study and a statement as to 
whether the activities at all organisations are the same or different. 
 
There is one site involved in this study, all research activities as detailed in the study documents 
will take place at site. 
 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
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organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence. For further guidance on working with 
participating NHS organisations please see the HRA website. 
 
If Chief Investigators, sponsors or Principal Investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the Chief Investigator, sponsor or Principal Investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent 
approach to information provision. 
 
 
 
Confirmation of Capacity and Capability  
 
This describes whether formal confirmation of capacity and capability is expected from participating 
NHS organisations in England. 
 
Participating NHS organisations in England will be expected to formally confirm their 
capacity and capability to host this research. 
 
 Following issue of this letter, participating NHS organisations in England may now confirm to the 
 sponsor their capacity and capability to host this research, when ready to do so. How capacity 
 and capacity will be confirmed is detailed in the Allocation of responsibilities and rights are 
 agreed and documented (4.1 of HRA assessment criteria) section of this appendix.
   
3. The Assessing, Arranging, and Confirming document on the HRA website provides further 
    
 information for the sponsor and NHS organisations on assessing, arranging and 
 confirming capacity and capability. 
 
 
Principal Investigator Suitability  
 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
 
A PI is expected at site and this will be the CI. 
 
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations. 
 
 
HR Good Practice Resource Pack Expectations  
 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement 
checks that should and should not be undertaken 
 
The student working on the project should be covered as part of a healthcare placement and the CI is 
already employed at the site. Therefore no honorary research contracts or letters of access are 
expected for this study. 
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Other Information to Aid Study Set-up  
 
This details any other information that may be helpful to sponsors and participating NHS 
organisations in England to aid study set-up. 
 
The applicant has indicated that they do not intend to apply for inclusion on the NIHR CRN 
Portfolio.  
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Dr Flannigan  Mr Alex Astor 
School of Dentistry Head of Liverpool Joint Research 
University of Liverpool  Office 
Pembroke Place 
University of Liverpool Liverpool 
Merseyside Research Support Office 
L3 5PS 2nd Floor Block D Waterhouse 
  Building 
 3 Brownlow Street 
  Liverpool 
  L69 3GL 
02 August 2016 
Tel: 0151 794 8739 
Email: sponsor@liv.ac.uk 
Sponsor Ref: UoL001233   
 
Re: Sponsorship Approval 
 
“The use of the Q-Scan oral hygiene device for plaque identification as part of an at-home oral  
hygiene routine and to assess its influence on plaque accumulation and enamel” 
 
 
Dear Dr Flannigan 
 
After consideration at the JRO Non Interventional Sponsorship Sub Committee on 18
th
 July 2016 I am pleased 
to confirm that the University of Liverpool is prepared to act as Sponsor under the  
Department of Health’s Research Governance Framework for Health and Social Care 2
nd
 Edition (2005) for the 
above study. 
 
The following documents have been received by the Joint Research Office 
 
Document title Version Date 
Protocol 1 10/06/2016 
QScan CE certificate 1 20/06/2016 
Information Sheet (Children) 1 20/06/2016 
Information Sheet (Parents) 1 20/06/2016 
Information Sheet (Participant) 1 20/06/2016 
Assent Form 1 20/06/2016 
Consent Form 1 1 20/06/2016 
Consent Form 2 1 20/06/2016 
Debriefing Form 1 20/06/2016 
 
Please note this letter does NOT allow you to commence recruitment to your study. 
 
 
TEM012 JRO UoL Sponsor Approval template 
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requirements have been met. Please see Appendix 1 to this letter for a list of the documents required. 
 
If you have not already applied for regulatory approvals through IRAS you may now do so at 
https://www.myresearchproject.org.uk/Home.aspx. 
 
In order to meet the requirements of the Research Governance Framework 2
nd
 Ed 2005, the 
University requires you to agree to the following Chief Investigator responsibilities: 
 
1. Comply with the Research Governance Framework 2
nd
 Ed 2005 and all relevant legislation, 
including but not limited to the Data Protection Act 1998, the Mental Capacity Act 2005 and 
the Human Tissue Act 2004; 
 
2. Inform the Research Support Office as soon as possible of any adverse events especially 
 
SUSARs and SAE’s, Serious Breaches to protocol or relevant legislation or any concerns regarding research 
conduct; 
 
3. Approval must be gained from the Research Support Office for any amendments to, or 
changes of status in the study prior to submission to REC and any other regulatory 
authorities; 
 
4. It is a requirement that Annual Progress Reports are sent to the NHS Research Ethics 
Committee (REC) annually following the date of Favourable Ethical Approval. You must 
provide copies of any reports submitted to REC and other regulatory authorities to the 
Research Support Office; 
 
5. Maintain the study master file; 
 
6. Make available for review any study documentation when requested by the sponsors 
and regulatory authorities; 
 
7. Upon the completion of the study it is a requirement to submit and an End of Study 
Declaration (within 90 days of the end of the study) and End of Study Report to REC (within 
12 months of the end of the study). You must provide copies of this to the Research 
Support Office; 
 
8. Ensure you and your study team are up to date with the current RSO SOPs throughout 
the duration of the study. 
 
The University also requires you to comply with the following: 
 
1. University professional indemnity and clinical trials insurances will apply to the study as 
appropriate. This is on the assumption that no part of the clinical trial will take place  
TEM012 JRO UoL Sponsor Approval template 
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you wish to sub-contract any part of the study to a third party specific approvals and consideration of 
appropriate indemnity would be required. 
 
If you have any queries regarding the sponsorship of the study or the above conditions, please do not hesitate 
to contact the Joint Research Office governance team on 0151 794 8373 (email sponsor@liv.ac.uk). 
 
Yours sincerely  
 
 
 
 
pp Karen Wilding 
Mr Alex Astor  
Head of Liverpool Joint Research Office 
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Appendix 14: Insurance cover 
 
 
 
Katie Booth  
Client Advisor  
National Corporate Practice  
 
Marsh Ltd  
Belvedere 
12 Booth Street  
Manchester  
M2 4AW 
+44 (0) 161 954 7200  
Fax +44 (0) 161 954 7210  
Katie.X.Dalton@marsh.com  
www.marsh.com 
 
 
 
 
 
 
 
2 August 2016 
 
To whom it may concern 
 
 
 
Dear Sirs 
 
CONFIRMATION OF INSURANCE – The University of Liverpool 
 
As requested by the above client, we are writing to confirm that we act as Insurance Brokers to the client 
and that we have arranged insurance(s) on its behalf as detailed below: 
 
CLINICAL TRIALS 
 
INSURER: 
 
Novae Underwriting Limited 
 
POLICY NUMBER: 
 
019540MMA16C 
 
PERIOD OF INSURANCE: 
 
1 August 2016 – 31 July 2017 
 
INDEMNITY LIMIT: 
 
GBP5,000,000 any one event and in all the period of 
Insurance or any applicable Extended Discovery period. 
 
DEDUCTIBLES: 
 
GBP5,000 any one claim including costs and expenses. 
 
 
We have placed the insurance which is the subject of this letter after consultation with the client and based upon the 
client’s instructions only. Terms of coverage, including limits and deductibles, are based upon information furnished 
to us by the client, which information we have not 
 
 
 
 
 
 
 
 
Registered in England and Wales Number: 1507274, Registered Office:   
1 Tower Place West, Tower Place, London EC3R 5BU. Marsh Ltd is authorised and regulated by the Financial Conduct Authority.  
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independently verified. 
 
This letter is issued as a matter of information only and confers no right upon you other than those provided 
by the policy. This letter does not amend, extend or alter the coverage afforded by the policies described 
herein. Notwithstanding any requirement, term or condition of any contract or other document with respect to 
which this letter may be issued or pertain, the insurance afforded by the policy (policies) described herein is 
subject to all terms, conditions, limitations, exclusions and cancellation provisions and may also be subject to 
warranties. Limits shown may have been reduced by paid claims. 
 
We express no view and assume no liability with respect to the solvency or future ability to pay of any of the 
insurance companies which have issued the insurance(s). 
 
We assume no obligation to advise yourselves of any developments regarding the insurance(s) subsequent 
to the date hereof. This letter is given on the condition that you forever waive any liability against us based 
upon the placement of the insurance(s) and/or the statements made herein with the exception only of wilful 
default, recklessness or fraud. 
 
This letter may not be reproduced by you or used for any other purpose without our prior written consent. 
 
This letter shall be governed by and shall be construed in accordance with English law. 
 
Yours faithfully, 
 
Katie Booth 
 
Katie Booth  
Client Advisor 
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